[
    {
        "utterance": "Dr. Anna Moore: Sandin at the College of Human Medicine. Uh prior to joining MSU, which was about three years ago, uh my career all my career pretty much went at Massachusetts General Hospital and Harvard Medical School that I joined as postdoctoral fellow and by the time I left I was a professor at Harvard Medical School, professor in radiology. So, uh my personal interest in science is image guided therapy for metastatic cancers. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share expertise",
                    "definition": "Sharing one's professional background and expertise.",
                    "justification": "Dr. Anna Moore shares her career background at Massachusetts General Hospital and Harvard Medical School, and her role at the College of Human Medicine. 'Sandin at the College of Human Medicine. Uh prior to joining MSU, which was about three years ago, uh my career all my career pretty much went at Massachusetts General Hospital and Harvard Medical School that I joined as postdoctoral fellow and by the time I left I was a professor at Harvard Medical School, professor in radiology.'"
                },
                {
                    "code_name": "express interest",
                    "definition": "Expressing a personal interest in a scientific area.",
                    "justification": "Dr. Anna Moore expresses her personal interest in image-guided therapy for metastatic cancers. 'So, uh my personal interest in science is image guided therapy for metastatic cancers.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Um, in the beginning of my career, I used uh iron oxide nanoparticles as contrast agents uh to detect tumors and now we're using them actually as uh carriers as vehicles to deliver therapies and as imaging reporters as well, that's why it's image guided therapy. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share expertise",
                    "definition": "Sharing professional background or research experience.",
                    "justification": "Dr. Moore shares her research experience: 'Um, in the beginning of my career, I used uh iron oxide nanoparticles as contrast agents uh to detect tumors and now we're using them actually as uh carriers as vehicles to deliver therapies and as imaging reporters as well, that's why it's image guided therapy.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: So that's it. Um, I mean, I can take tell you more, but I think we should try to keep it short. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "self_limiting",
                    "definition": "The speaker intentionally limits the extent of their disclosure or discussion.",
                    "justification": "The utterance 'I can tell you more, but I think we should try to keep it short' indicates Dr. Moore's decision to not elaborate further to keep the discussion brief."
                },
                {
                    "code_name": "suggest_time_management",
                    "definition": "The speaker suggests managing the time allocated for a discussion.",
                    "justification": "The phrase 'I think we should try to keep it short' supports this code, as it directly relates to managing the discussion time."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: So, um, I I'm just going to go the way I see people on the screen, so no or or no, I do have a list here. Okay, let's just go alphabetically. Benjamin. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "organize discussion",
                    "definition": "The speaker is taking charge of how the discussion or meeting will proceed.",
                    "justification": "The exact quotes 'So, um, I I'm just going to go the way I see people on the screen... Okay, let's just go alphabetically' indicate this behavior."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Hi. Uh, I'm Ben Benjamin Bartel. I'm assistant professor just started this year at Arizona State University. I work on uh molecular tools for MRI. My goal is to uh non-invasively resolve and manipulate the neuroimmune system. So I do that with a combination of um uh just direct MRI methods uh through um just image analysis and I also build a host of molecular tools using directed evolution, signaling reporters, direct molecular sensors, etc. all for MRI and all in vivo. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce_self",
                    "definition": "The speaker introduces themselves, potentially for the first time in the meeting or context.",
                    "justification": "Hi. Uh, I'm Ben Benjamin Bartel. I'm assistant professor just started this year at Arizona State University."
                },
                {
                    "code_name": "state_research_area",
                    "definition": "The speaker mentions their field of research or area of expertise.",
                    "justification": "I work on uh molecular tools for MRI."
                },
                {
                    "code_name": "propose_idea_or_goal",
                    "definition": "The speaker shares a goal or idea related to their research.",
                    "justification": "My goal is to uh non-invasively resolve and manipulate the neuroimmune system."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: We met yesterday, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "establish familiarity",
                    "definition": "Attempt to create a connection or recall a previous interaction with someone.",
                    "justification": "The speaker is trying to recall a previous meeting to establish a connection. Exact quote: \"We met yesterday, right?\""
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Yeah, I think we did. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, they screwed up a little bit the facilitators and the group, so I was supposed to be in the other group at the beginning. So, but that's fine. So it's all good to see faces that you've seen before. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "small talk",
                    "definition": "Making casual comments or jokes to ease into the conversation or establish a rapport.",
                    "justification": "The speaker mentions a minor mistake to explain their presence, showing a casual approach to initiating conversation. ('Yeah, they screwed up a little bit the facilitators and the group...')"
                },
                {
                    "code_name": "positive sentiment expression",
                    "definition": "Expressing a positive feeling or attitude towards a situation or person.",
                    "justification": "The speaker expresses acceptance and happiness about the situation, focusing on a positive outcome. ('So, but that's fine. So it's all good to see faces that you've seen before.')"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: All right. Uh Molly. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: Hi, I'm Molly Bright. I'm at Northwestern in Chicago. Uh, I also do in vivo work with MRI, but with humans. Um, I mostly look at quantifying aspects of the plumbing. So blood flow supplied to the tissue, how that blood flow is regulated or misregulated, um, aspects of oxygen delivery and metabolism. Uh, but I also like to think about how all of that vascular infrastructure supports or doesn't support healthy neural function. So, um, I do a lot of work now in in patients thinking about rehabilitation. So what can we do after something's happened to try to recover and repair both the neural and vascular systems. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Introduce Self",
                    "definition": "The speaker introduces themselves and provides their background.",
                    "justification": "Hi, I'm Molly Bright. I'm at Northwestern in Chicago."
                },
                {
                    "code_name": "Describe Research",
                    "definition": "The speaker describes their current research or area of expertise.",
                    "justification": "I mostly look at quantifying aspects of the plumbing. So blood flow supplied to the tissue, how that blood flow is regulated or misregulated, um, aspects of oxygen delivery and metabolism."
                },
                {
                    "code_name": "Express Interest in Collaboration/Inquiry",
                    "definition": "The speaker expresses interest in a specific area that could lead to collaboration or inquiry.",
                    "justification": "So what can we do after something's happened to try to recover and repair both the neural and vascular systems."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. Wonderful. Dylan. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: Hi, I'm Dylan Burnette. Um, I am an associate professor at Vanderbilt University. I just am just barely on the other side of tenure now. Uh although I still feel like I have like new people problems. Um, but I am a cell biologist by training and so I've been using light microscopes for about 20 years or so, a little bit more unfortunately. Um as I'm getting older. Uh to to study uh the cell skeleton. And so my my lab we kind of took that interest in in the cell skeleton to ask a very simple question. How does a heart grow on a single cell level? Meaning how does a single heart muscle cell physically get bigger? And that is one of the main drivers of our lab. Uh and we do attack that in multiple ways and it occurred to us a few years ago, actually about a year ago now that we could use the same technologies we're using to start mimicking what's happening inside of patients in in a in a uh basically a dish. And so we are now developing uh systems to mimic ischemia and reperfusion injury in our cardiac myos and that's allowed us to start doing screening and I have no idea what I'm doing and it's phenomenal. I have we're having a very good time. Uh and so we are kind of all over the place. We're we're looking at individual sarcomeres and we're looking to find some drugs. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce_self",
                    "definition": "The speaker introduces themselves, their position, and their institution.",
                    "justification": "The speaker starts by introducing themselves: \"Hi, I'm Dylan Burnette. Um, I am an associate professor at Vanderbilt University.\""
                },
                {
                    "code_name": "share_research_background",
                    "definition": "The speaker shares their background in research and their area of study.",
                    "justification": "The speaker explains their background and research focus: \"I am a cell biologist by training and so I've been using light microscopes for about 20 years or so... to study uh the cell skeleton.\""
                },
                {
                    "code_name": "describe_current_research",
                    "definition": "The speaker describes their current research projects and goals.",
                    "justification": "The speaker elaborates on their current research: \"And so my my lab we kind of took that interest in in the cell skeleton to ask a very simple question. How does a heart grow on a single cell level?... And so we are now developing uh systems to mimic ischemia and reperfusion injury in our cardiac myos and that's allowed us to start doing screening\""
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. All right, sounds good. Morteza. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none",
                    "definition": "No relevant behavior observed.",
                    "justification": "The utterance is very brief and serves primarily as a transition."
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi: Hi, my name is Morteza Mahmoudi and uh I'm an assistant professor at Michigan State University. My work is uh focused on nanomedicine and regenerative medicine and basically we use imaging technique to basically probe nanoparticles. if we use them for like therapeutic approaches like MRI approaches, if we use like magnetic based nanoparticles. Uh, but uh most importantly we try to understand what happens at the surface of nanoparticles. So for that purpose we combine cryo transmission electron microscopy and uh 3D constructed imaging model to basically see the 3D structure of the nanoparticles and how they interact with proteins and at the larger scale how they interact with different cell types and what are their uh trafficking inside the cells. ",
        "annotations": {}
    },
    {
        "utterance": "Morteza Mahmoudi: Paris. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Paris Perdikaris: Hello everyone. So my name is Paris Perdicarris and I'm assistant professor at the Department of Mechanical Engineering at the University of Pennsylvania. Um, my background actually is in applied mathematics and my work is focused on developing machine learning methods and computational tools for modeling and simulation of physical and biological systems. I think most relevant to this meeting in some is some work I'm pursuing on physics based filtering of um uh in vivo MRI uh with a focus on 4D flow MRI and reconstructing blood flow and measurements in a way that the underlying physics is satisfied, so principles like mass and momentum conservation and then using those principles to infer auxiliary measurements that um cannot be measured by imaging such as blood pressure, uh shear stresses, um uh and so forth. So the idea there is really to understand the role of hemodynamics in determining organ function and uh you know, predicting biomarkers that are relevant to cardiovascular disease. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Introduce Self",
                    "definition": "The speaker introduces themselves, their position, and their background.",
                    "justification": "The speaker starts by introducing themselves, \"Hello everyone. So my name is Paris Perdicarris and I'm assistant professor at the Department of Mechanical Engineering at the University of Pennsylvania.\""
                },
                {
                    "code_name": "Describe Research",
                    "definition": "The speaker describes their research background and interests.",
                    "justification": "The speaker explains their background and research focus, \"my background actually is in applied mathematics and my work is focused on developing machine learning methods and computational tools for modeling and simulation of physical and biological systems.\""
                },
                {
                    "code_name": "Discuss Specific Project",
                    "definition": "The speaker discusses a specific project or area of research they are working on.",
                    "justification": "The speaker elaborates on a specific project, \"I think most relevant to this meeting in some is some work I'm pursuing on physics based filtering of um uh in vivo MRI uh with a focus on 4D flow MRI and reconstructing blood flow and measurements in a way that the underlying physics is satisfied...\""
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Wonderful, Lisa. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: Hi everyone, I'm Lisa Poulikakos. I'm an assistant professor at UC San Diego. My research works on nanophotonics, so the study and manipulation of light at the nanoscale. Um, and some questions I'm really interested in is how can we scale down the complex manipulation of light. So a lot of these really sophisticated imaging techniques using state of the art nano optics can actually be realized on a single optical surface, which is then uh nano patterned in intricate ways and then can really be easily deployed in a variety of in vivo and ex vivo applications. Um and some questions that I find interesting um recently are how can we uh enhance polarized light matter interactions to learn more about the structural properties of molecules or tissues, for example. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce self",
                    "definition": "The speaker provides personal and professional introduction.",
                    "justification": "Hi everyone, I'm Lisa Poulikakos. I'm an assistant professor at UC San Diego."
                },
                {
                    "code_name": "describe research",
                    "definition": "The speaker explains their current research or area of work.",
                    "justification": "My research works on nanophotonics, so the study and manipulation of light at the nanoscale."
                },
                {
                    "code_name": "ask question",
                    "definition": "The speaker asks for information or clarification on a topic.",
                    "justification": "how can we scale down the complex manipulation of light and how can we uh enhance polarized light matter interactions."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay, thank you. Crystal. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Expressing recognition or acknowledgment of someone or something.",
                    "justification": "The utterance acknowledges Crystal with 'Crystal.'"
                },
                {
                    "code_name": "show appreciation",
                    "definition": "A polite expression to show thanks.",
                    "justification": "The phrase 'thank you' explicitly shows appreciation."
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: Hi everyone. Uh my name is Crystal Rogers and I am an assistant professor at UC Davis. I am a developmental uh molecular and cell biologist and my research focuses on on understanding um the roles of transcription factors and cell cell adhesion molecules in regulating the process of the epithelial to transition. So I study neural crest cells um and those cells are really dynamic and they make a lot of different um adult tissues, but probably more relevant to this group, uh all of the molecular mechanisms that allow those cells to undergo EMT are then re uh reused by cancer cells to metastasize. And so what we are doing in my lab is really trying to get at the basal function of the proteins that allow these cells to undergo EMT and to migrate and differentiate and then um at least my postdoc is really interested in trying to define whether those functions um are conserved in disease states. And so we do a lot of fixed and live imaging of these cells to get at um how the collective migration works um and and the paths that these cells take and then um hopefully how that's affected by perturbations of these different proteins. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce self",
                    "definition": "The speaker introduces themselves, their position, and their field of study.",
                    "justification": "The speaker introduces herself as Crystal Rogers, an assistant professor at UC Davis, and describes her field of study."
                },
                {
                    "code_name": "describe research",
                    "definition": "The speaker describes their current research and its relevance to the discussion.",
                    "justification": "She explains her research focuses on understanding the roles of transcription factors and cell adhesion molecules in regulating EMT, studying neural crest cells."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Very, very interesting. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express interest",
                    "definition": "The speaker expresses interest or enthusiasm about what was just said.",
                    "justification": "The utterance 'Very, very interesting.' shows Dr. Anna Moore's interest in what was previously discussed by Lisa Poulikakos and Crystal Rogers. The verbatim quote is 'Very, very interesting.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Right in line with what we're doing too, so okay. Uh Mark. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "align",
                    "definition": "The speaker indicates agreement or alignment with a previous statement.",
                    "justification": "The speaker says 'Right in line with what we're doing too', showing alignment with previous work."
                },
                {
                    "code_name": "transition",
                    "definition": "The speaker attempts to move the conversation forward or shift the attention.",
                    "justification": "The speaker then says 'Uh Mark', indicating an attempt to transition or pass the conversation to Mark."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: that we can't do at this point. And another the other component is really around imaging gene and cell therapies and if we can image it and control it then perhaps we can get into that, you know, positive feedback loop of modulating something in the therapy and then seeing how that changes. So, um, thanks. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or approach for research or investigation.",
                    "justification": "The utterance contains \"imaging gene and cell therapies and if we can image it and control it then perhaps we can get into that, you know, positive feedback loop of modulating something in the therapy,\" which clearly outlines a proposed idea for research."
                },
                {
                    "code_name": "reference limitation",
                    "definition": "The speaker mentions something that is currently not possible or a limitation.",
                    "justification": "The phrase \"that we can't do at this point\" directly indicates a limitation or constraint being acknowledged."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. And uh I just don't want to mispronounce your name. Sixian, Sixian, is that the right way to say it? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "show consideration",
                    "definition": "Showing consideration for others' feelings or comfort level.",
                    "justification": "Dr. Anna Moore shows consideration for Sixian's name by asking if she is pronouncing it correctly. Evidence: 'Okay. And uh I just don't want to mispronounce your name. Sixian, Sixian, is that the right way to say it?'"
                },
                {
                    "code_name": "initiate interaction",
                    "definition": "Initiating an interaction with someone, often to start a conversation.",
                    "justification": "Dr. Anna Moore initiates an interaction with Sixian by addressing him directly and asking about his name. Evidence: 'Okay. And uh I just don't want to mispronounce your name. Sixian, Sixian, is that the right way to say it?'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Uh, yeah, close enough. So my name is uh Sixian You. Yes. Uh, so I'm assistant professor in electrical engineering at MIT. I just started uh this March. Uh, I did my PhD in UIUC uh in label free microscopy. And then I did my uh postdoc in Berkeley in computational imaging. So my new lab uh the goal is to see how to use optics and algorithms to enable breakthroughs in biomedicine, especially the clinical adoption of microscopy in different uh biomedical situations like early cancer diagnosis, image guided therapies and neuroimaging. So I'm very interesting this session uh the reason I've never done anything like image guided therapies before, but uh I'm very curious how can I contribute? How can I use label free imaging, how can I use optics and algorithms to enable point of procedure diagnosis uh or point of procedure real time monitoring of the therapeutic process. Uh, what role would a resolution of cellular dynamics mean in the in the process of imaging guided therapies. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce self",
                    "definition": "The speaker provides information about themselves, their professional background, and their current position.",
                    "justification": "The speaker introduces himself with his name, position, and background: \"So my name is uh Sixian You. Yes. Uh, so I'm assistant professor in electrical engineering at MIT. I just started uh this March. Uh, I did my PhD in UIUC uh in label free microscopy. And then I did my uh postdoc in Berkeley in computational imaging.\""
                },
                {
                    "code_name": "express interest",
                    "definition": "The speaker shows curiosity and eagerness to engage with the topic or session.",
                    "justification": "The speaker expresses interest in the session and a desire to contribute: \"So I'm very interesting this session uh the reason I've never done anything like image guided therapies before, but uh I'm very curious how can I contribute?\""
                },
                {
                    "code_name": "ask question",
                    "definition": "The speaker seeks information or clarification on specific points.",
                    "justification": "The speaker asks questions about potential contributions and the role of certain technologies: \"How can I contribute? How can I use label free imaging, how can I use optics and algorithms to enable point of procedure diagnosis uh or point of procedure real time monitoring of the therapeutic process. Uh, what role would a resolution of cellular dynamics mean in the in the process of imaging guided therapies.\""
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. Thank you so much. And then there's other people who are not on my list. I don't know if you guys want to introduce yourself. Um. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "invite introduction",
                    "definition": "The speaker invites others to introduce themselves.",
                    "justification": "The utterance contains a direct invitation for others to introduce themselves, as evidenced by \"I don't know if you guys want to introduce yourself.\""
                },
                {
                    "code_name": "acknowledge others",
                    "definition": "The speaker acknowledges the presence of others not listed.",
                    "justification": "The speaker mentions \"And then there's other people who are not on my list,\" which acknowledges the presence of others."
                }
            ]
        }
    },
    {
        "utterance": "Arne Bakker (he/him) | CZI: So I'll just briefly say hi if that's okay just to you know who I am. I'm Arne Bakker, I'm at CZI, I'm the director of meetings and community um and so me and my team we host meetings like this about 15 to 20 times a year for the the the the scientists that CZI funds to really uh hope to encourage collaboration and sharing of knowledge. Um and I have a PhD in immunology and did my postdoc at Berkeley and my PhD at the Netherlands Cancer Institute in Amsterdam uh hence my interest in this topic. Uh but I'm mostly here to observe so I'm going to probably throw my camera off and and listen in but uh looking forward to hearing the conversation. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Introduce Self",
                    "definition": "The speaker provides their name, affiliation, and background information.",
                    "justification": "The speaker introduces themselves with their name, position, and background: 'I'm Arne Bakker, I'm at CZI, I'm the director of meetings and community... I have a PhD in immunology and did my postdoc at Berkeley and my PhD at the Netherlands Cancer Institute in Amsterdam.'"
                },
                {
                    "code_name": "State Observational Role",
                    "definition": "The speaker mentions they are primarily there to observe or listen.",
                    "justification": "The speaker states they are 'mostly here to observe' and plan to listen in: 'but I'm mostly here to observe so I'm going to probably throw my camera off and and listen in'"
                },
                {
                    "code_name": "Express Interest",
                    "definition": "The speaker expresses their interest or engagement with the topic or meeting.",
                    "justification": "The speaker shows interest in the topic and the conversation: 'hence my interest in this topic... looking forward to hearing the conversation.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. And uh Sandra, do you want to say a couple of words? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "invite to share",
                    "definition": "The speaker invites another participant to share their thoughts or introduce themselves.",
                    "justification": "The speaker directly addresses Sandra and asks if she wants to say a couple of words. Evidence: 'Okay. And uh Sandra, do you want to say a couple of words? '"
                }
            ]
        }
    },
    {
        "utterance": "Sandra Laney - Walder Foundation: Yeah, just really quickly. I'm I'm a guest. I'm from the Walder Foundation based in the Chicago region um and I'm the senior program uh director for science innovation. So really just here as an observer looking forward to hearing the conversation. I also will probably shut my camera off and just participate as a butterfly on the wall. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduction",
                    "definition": "The act of introducing oneself, often including their name, affiliation, or role.",
                    "justification": "Sandra introduces herself with her name and professional details: 'I'm Sandra Laney - Walder Foundation: Yeah, just really quickly. I'm I'm a guest. I'm from the Walder Foundation based in the Chicago region um and I'm the senior program uh director for science innovation.'"
                },
                {
                    "code_name": "state intentions",
                    "definition": "Clearly expressing one's intentions or purposes for being part of the conversation.",
                    "justification": "Sandra states her intention to be an observer and possibly participate minimally: 'So really just here as an observer looking forward to hearing the conversation. I also will probably shut my camera off and just participate as a butterfly on the wall.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. Um so um I guess the first thing we need to do is to select a person uh who's going to be recording uh all the great thoughts that hopefully come come out of this meeting. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a plan or idea for the group.",
                    "justification": "The utterance 'I guess the first thing we need to do is to select a person uh who's going to be recording uh all the great thoughts that hopefully come come out of this meeting' is evidence of proposing an idea."
                },
                {
                    "code_name": "assign task",
                    "definition": "Giving a task to someone or a group.",
                    "justification": "The task of selecting a person to record thoughts is being assigned to the group."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: I did it last time, so I'm not going to do it this time, but it was actually very fun. So somebody else should have that opportunity. You're just writing down sketches and then everybody likes you because you did the work. So. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "show willingness to help",
                    "definition": "Expressing willingness or past experience in helping out with a task, even if not taking on the task this time.",
                    "justification": "The speaker mentions he did it last time and found it fun, indicating a positive experience and willingness to help. 'I did it last time, so I'm not going to do it this time, but it was actually very fun.'"
                },
                {
                    "code_name": "pass responsibility",
                    "definition": "Passing a task or responsibility to others, suggesting they should take it on.",
                    "justification": "The speaker suggests that somebody else should have the opportunity to do the task. 'So somebody else should have that opportunity.'"
                },
                {
                    "code_name": "describe task positively",
                    "definition": "Describing a task in a positive light, potentially to encourage others to take it on.",
                    "justification": "The speaker describes the task as making everyone like you because you did the work, in a positive tone. 'You're just writing down sketches and then everybody likes you because you did the work.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: That is very true Ben. So Ben did it the last time yesterday and he did an an amazing job. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Expressing agreement with a previous statement.",
                    "justification": "The utterance starts with 'That is very true Ben,' which indicates agreement with what Ben has previously stated."
                },
                {
                    "code_name": "praise",
                    "definition": "Giving positive feedback or acknowledging someone's work or achievement.",
                    "justification": "Dr. Anna Moore gives positive feedback to Ben by saying, 'So Ben did it the last time yesterday and he did an amazing job.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: And uh as uh Andrew pointed out, you don't need to fill up that slide uh right away because I guess I guess there's some I don't know, interference or something. My internet is not working very great either. So uh you can just write it down somewhere and then transfer it on the slide. So Ben, do you do you want to just basically give people like a couple of ideas how to do that? So they because they they will look a little bit scared. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Clarify/Explain",
                    "definition": "Providing clarification or explaining a point.",
                    "justification": "Dr. Anna Moore explains that there's no need to fill up a slide immediately. Evidence: 'And uh as uh Andrew pointed out, you don't need to fill up that slide uh right away...'"
                },
                {
                    "code_name": "Ask for Help/Assistance",
                    "definition": "Requesting help or assistance from others.",
                    "justification": "Dr. Anna Moore asks Ben for help. Evidence: 'So Ben, do you do you want to just basically give people like a couple of ideas how to do that?'"
                },
                {
                    "code_name": "Show Consideration",
                    "definition": "Showing concern for others' feelings or situations.",
                    "justification": "Dr. Anna Moore expresses concern for others looking scared. Evidence: 'So they because they they will look a little bit scared.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: Sure. We're um so you know, we all had a conversation yesterday that when people would make a point, they come in and say like, I don't know, we could one thing was we collect more data than we use these days. And so I just wrote that down. Somebody else said, you know, I'm involved in really these large scale projects and we try to collect data for other people. Like, okay, well, put those things together and I just started cluster together the the main points people were making. And they ended up being in about three general categories. And so at the end, I was like, hey everybody, things kind of went into these three categories. That's great. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "summarize",
                    "definition": "The speaker summarizes discussion points made by others.",
                    "justification": "The speaker mentions, 'I just wrote that down. Somebody else said... and I just started cluster together the the main points people were making.'"
                },
                {
                    "code_name": "share_experience",
                    "definition": "The speaker shares their experience or observations.",
                    "justification": "The speaker shares, 'we all had a conversation yesterday that when people would make a point...'"
                },
                {
                    "code_name": "facilitate",
                    "definition": "The speaker tries to facilitate the discussion.",
                    "justification": "The speaker says, 'And so at the end, I was like, hey everybody, things kind of went into these three categories. That's great.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Uh we we we sure did. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Expressing agreement or confirmation of a previous statement.",
                    "justification": "The utterance 'Uh we we we sure did.' serves as an acknowledgment of a previous statement."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: It's great to be appreciated. I'm just trying to sell it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express gratitude",
                    "definition": "Expressing thanks or appreciation for something.",
                    "justification": "The speaker says, 'It's great to be appreciated,' which directly indicates gratitude."
                },
                {
                    "code_name": "self-promotion",
                    "definition": "Indicating one's effort or ability to promote an idea or product.",
                    "justification": "The speaker mentions, 'I'm just trying to sell it,' which implies an effort to promote or sell an idea."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Thank you, appreciate that too. All right, so any volunteers? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express gratitude",
                    "definition": "The speaker is expressing thanks or appreciation.",
                    "justification": "The phrase 'Thank you, appreciate that too' clearly indicates Dr. Anna Moore expressing gratitude."
                },
                {
                    "code_name": "ask for volunteers",
                    "definition": "The speaker is soliciting volunteers for a task or activity.",
                    "justification": "The phrase 'All right, so any volunteers?' directly shows Dr. Anna Moore asking if there are any volunteers."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: That is what. I can do it. I'm a newbie in image guided therapies anyway, so I I'm here to absorb and learn. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "offer help",
                    "definition": "The speaker provides an offer to assist or take on a task.",
                    "justification": "The utterance 'I can do it' directly indicates an offer to help."
                },
                {
                    "code_name": "position self",
                    "definition": "The speaker explicitly states their level of expertise or position within the context of the discussion.",
                    "justification": "The phrase 'I'm a newbie in image guided therapies anyway' serves as a self-positioning statement."
                },
                {
                    "code_name": "express to learn",
                    "definition": "The speaker mentions their goal to gain knowledge or insights.",
                    "justification": "The statement 'I'm here to absorb and learn' clearly expresses the intent to learn."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. Sixian, thank you so much. That's uh great. So it's actually up to you. You can write, you know, write in the slide if you want. It's up to you or on the, you know, piece of paper on or on the computer screen and then. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "delegation",
                    "definition": "Assigning a task or decision to another person.",
                    "justification": "The speaker is giving Sixian the responsibility to decide how to proceed with writing or presenting information. Evidence: 'So it's actually up to you. You can write, you know, write in the slide if you want. It's up to you or on the, you know, piece of paper on or on the computer screen and then.'"
                },
                {
                    "code_name": "expression of appreciation",
                    "definition": "Expressing thanks or appreciation.",
                    "justification": "Dr. Anna Moore is thanking Sixian for something. Evidence: 'Sixian, thank you so much. That's uh great.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Uh, yes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Acknowledge or confirm a statement.",
                    "justification": "The utterance 'Uh, yes.' is a clear acknowledgement of a previous statement. The verb 'yes' indicates agreement or confirmation."
                },
                {
                    "code_name": "show willingness",
                    "definition": "Indicate a willingness to cooperate or participate.",
                    "justification": "Although not strongly indicative, 'Uh, yes.' can be seen as a minimal expression of cooperation or willingness to engage."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: No, no, no, it's slide 42. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "correct",
                    "definition": "The act of correcting or making clear a previous statement or piece of information.",
                    "justification": "The use of 'No, no, no' indicates a correction or a strong clarification, and 'it's slide 42' specifies the correct information."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: 42. Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Uh, it's the recovery slide or is the original slide? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The act of seeking information or clarification.",
                    "justification": "The utterance 'Uh, it's the recovery slide or is the original slide?' directly asks for information about the slide, indicating uncertainty."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright, Northwestern: Whichever one is for our room. It doesn't matter what number slide it is. If it's the one for 2.3. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "show flexibility",
                    "definition": "The speaker shows willingness to adapt or accommodate others' preferences without expressing a strong personal preference.",
                    "justification": "Whichever one is for our room. It doesn't matter what number slide it is."
                },
                {
                    "code_name": "express conditional agreement",
                    "definition": "The speaker agrees under certain conditions.",
                    "justification": "If it's the one for 2.3."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos, UCSD: So we're saying there's versions of the document and we should use the one that doesn't say recovery somehow just so if I understood correctly. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The exact quote 'So we're saying there's versions of the document and we should use the one that doesn't say recovery somehow just so if I understood correctly' indicates a questioning tone aimed at confirming understanding."
                },
                {
                    "code_name": "clarify",
                    "definition": "The speaker is trying to make sure they understand the situation correctly.",
                    "justification": "The phrase 'just so if I understood correctly' directly points to an effort to clarify."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright, Northwestern: Got it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "The speaker acknowledges or confirms understanding of previous information.",
                    "justification": "The utterance 'Got it.' is a clear acknowledgment of previous information. The speaker, Molly Bright, is confirming that she understands the discussion.",
                    "char_offsets": [
                        0,
                        7
                    ]
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: That makes sense. Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Acknowledge or show understanding of a previous statement.",
                    "justification": "The utterance 'That makes sense. Okay.' acknowledges that the speaker understands the previous conversation. Evidence: 'That makes sense.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, I have a slide that doesn't say recovery. Well, okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "The speaker acknowledges or confirms something previously said or done.",
                    "justification": "Dr. Anna Moore is acknowledging she has a slide that fits a certain criterion ('Yeah, I have a slide that doesn't say recovery.'). The phrase 'Yeah' and 'Well, okay' are indicators of acknowledgment."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: already entered her name. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, you can just do that. Okay, great, excellent. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Expressing agreement or acknowledgment of a previous statement.",
                    "justification": "The utterance 'Yeah, you can just do that. Okay, great, excellent.' acknowledges a previous statement with a positive tone, as evident from the quote 'Okay, great, excellent.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: All right, so here we go. Um from models to humans. Um so basically the question is we have uh a lot of uh drugs in the pipeline in in uh petri dishes in the labs uh that were beautifully uh when you seed the cells, you know, and then you sprinkle the drug, cells dead, all good. Uh, totally different issues when you start injecting something in the body, whether it's a mouse, a rat or or human. Well, you can't inject in the human before you inject in the mouse and the rat but anyway, so the big issue is how do you how do you get something somewhere where it needs to go? What are the biological barriers that needs to be overcome? Uh, and the biggest question, I guess, you all know that it takes about 10 years to get something from the bench to to being somewhat approved. Not even fully approved, but somewhat approved. 10 years, uh, tens of millions, sometimes hundred millions of dollars. Just just something has to something has to be done about that. So, um, so we're here to to solve this problem today. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "introduce topic",
                    "definition": "Introducing a new topic or area of discussion.",
                    "justification": "The utterance starts with 'All right, so here we go. Um from models to humans,' indicating the introduction of a new topic."
                },
                {
                    "code_name": "highlight challenge",
                    "definition": "Pointing out difficulties or obstacles.",
                    "justification": "The speaker mentions 'totally different issues when you start injecting something in the body,' and 'it takes about 10 years to get something from the bench to being somewhat approved. Not even fully approved, but somewhat approved. 10 years, uh, tens of millions, sometimes hundred millions of dollars,' highlighting significant challenges."
                },
                {
                    "code_name": "express urgency",
                    "definition": "Indicating a need for action or change.",
                    "justification": "The speaker says, 'Just just something has to something has to be done about that. So, um, so we're here to to solve this problem today,' expressing a sense of urgency and the need for action."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers (UC Davis): So as a mechanistic scientist, I just want to to bring up this, you know, start at the base level basically, that the issue or one of the big issues that we have with this is that the con. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "offer criticism",
                    "definition": "The speaker presents a negative comment or an issue with the current discussion or idea.",
                    "justification": "The speaker mentions 'one of the big issues that we have with this is that the con,' indicating a critique."
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or perspective.",
                    "justification": "The speaker wants to 'start at the base level basically,' indicating a new perspective."
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers (UC Davis): of these processes or or you know, pathways, they're not even conserved between people, much less species. And so we have a really uh significant issue if we focus on one model organism and there's no confirmation of of pathways, molecular pathways for treatments. And so as you mentioned, something can be targeted in the mouse and never works in the human and doing research with model organisms, even closely related ones, I can tell you that even within the same order, there's no guarantee that these species have um kind of the same there's not the mechanistic processes aren't the same. So I think we need a lot more basic level research to really define what the conserved pathways that drive these processes of say EMT, cell migration, metastasis are, um before we can jump to treating humans and and we have to have both of those at the same time in my opinion. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "The speaker expresses worry about a particular issue.",
                    "justification": "The speaker expresses concern about using one model organism without confirmation of pathways, stating 'we have a really uh significant issue if we focus on one model organism and there's no confirmation of of pathways, molecular pathways for treatments.'"
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or approach.",
                    "justification": "The speaker proposes the need for more basic level research, stating 'So I think we need a lot more basic level research to really define what the conserved pathways that drive these processes of say EMT, cell migration, metastasis are, um before we can jump to treating humans'"
                },
                {
                    "code_name": "provide explanation",
                    "definition": "The speaker provides a reason or explanation for their statement.",
                    "justification": "The speaker explains the issue with model organisms, stating 'even within the same order, there's no guarantee that these species have um kind of the same there's not the mechanistic processes aren't the same.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos (UCSD): Could I ask a follow up on on Crystal's comment? So I come from the optics and physics side so I'm just learning recently about the biological model making and so on. So how much do some of these relatively recent um 3D physiologically relevant cell culture models help? So so making basically um so so from you know, my reading and talking to some collaborators it seems like people are getting better at making in vitro models of of the human also for drug testing for example. So does that help maybe avoid some animal models or is that completely often brings along a whole other set of challenges? What's kind of the latest um state of the art there? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The utterance starts with 'Could I ask a follow up' and includes several interrogative phrases."
                },
                {
                    "code_name": "seek information from others' expertise",
                    "definition": "The speaker is looking for information or insights from others, potentially leveraging their expertise.",
                    "justification": "The speaker mentions their background and indicates they are learning about biological model making."
                },
                {
                    "code_name": "reference external information",
                    "definition": "The speaker references information obtained from external sources, such as literature or collaborators.",
                    "justification": "The speaker references 'my reading and talking to some collaborators'."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Are you talking like you know, like spheroid cultures and stuff? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "This code refers to the act of inquiring about something to seek information or clarification.",
                    "justification": "The utterance 'Are you talking like you know, like spheroid cultures and stuff?' is a clear indication of questioning about spheroid cultures."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos (UCSD): Mainly cell cultures that can reproduce for example also the extracellular environment. So so that are really physiologically relevant but in vitro. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide information",
                    "definition": "The speaker provides information or shares knowledge on a specific topic.",
                    "justification": "The utterance shares information about cell cultures, \"Mainly cell cultures that can reproduce for example also the extracellular environment. So so that are really physiologically relevant but in vitro.\""
                },
                {
                    "code_name": "describe methodology",
                    "definition": "The speaker describes a methodology or an approach related to their work or research.",
                    "justification": "The utterance describes a specific approach or condition of their research, \"Mainly cell cultures that can reproduce for example also the extracellular environment.\""
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: It feels very promising, but my personal experiment experience uh recently collaborating with somebody doing a 3D organoid model. Um we got all kinds of interesting data in addition that I went to go validate with some metabolic imaging, just nothing alike. Not even slightly. And so then we just did all the experiments over again and it told a completely different story. It turned out that, you know, sitting in millimolar glucose, which is what you have to do for the cells to survive, completely wrecked their metabolism in terms of you know, what we're looking for. So it is really easy to get to be misled by those tools. I'm not saying they're bad, but it's very easy to get misled because then you think they're real, but something that's required for the culture conditions um ruins everything. And for someone who works in neuroimmunity, like the microglia that I focus on, they know when they're in culture. They know when they're being looked at and they change their their gene transcription. So those things have been have been very frustrating for for my personal kind of work. Now, they may work in other systems, but they they've never worked for me. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Share Personal Experience",
                    "definition": "The speaker shares their personal experience or experiment results.",
                    "justification": "The speaker shares his recent collaboration experience with someone doing a 3D organoid model. Evidence: \"my personal experiment experience uh recently collaborating with somebody doing a 3D organoid model.\""
                },
                {
                    "code_name": "Discuss Challenges/Limitations",
                    "definition": "The speaker discusses challenges or limitations faced in their work or research.",
                    "justification": "The speaker discusses challenges with 3D organoid models and metabolic imaging. Evidence: \"So it is really easy to get to be misled by those tools.\""
                },
                {
                    "code_name": "Express Frustration",
                    "definition": "The speaker expresses frustration or difficulties encountered in their work.",
                    "justification": "The speaker expresses frustration with the tools and methods. Evidence: \"So those things have been have been very frustrating for for my personal kind of work.\""
                }
            ]
        }
    },
    {
        "utterance": "Sixian You | MIT: I think there are some positive examples for uh breast cancer. So there is a research group in Wisconsin Medicine where they uh have these organoids from patients and they culture it and then they use therapy to uh you know, treat it and then using optical imaging technologies, they are able to see if they decrease or increase. Uh I have not been following up how well that really translates to the patient's recovery because of course that takes long time to track. Uh but maybe the sensitivity. I know neurons are a beast. They are different in every different environment. So maybe some models are more robust in different um scenarios and that's the thing we could take advantage of. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a potential approach or idea for research or problem-solving.",
                    "justification": "So maybe some models are more robust in different um scenarios and that's the thing we could take advantage of."
                },
                {
                    "code_name": "provide information",
                    "definition": "Sharing knowledge or data relevant to the discussion.",
                    "justification": "So there is a research group in Wisconsin Medicine where they uh have these organoids from patients and they culture it and then they use therapy to uh you know, treat it and then using optical imaging technologies, they are able to see if they decrease or increase."
                },
                {
                    "code_name": "express caution",
                    "definition": "Indicating potential limitations or difficulties.",
                    "justification": "Uh I have not been following up how well that really translates to the patient's recovery because of course that takes long time to track."
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: Yes, I would I would get I would agree with that. Not all organoids are the same. Uh there are some organoids that are much more robust and in vivo like such as the gut organoids are actually making real crips to feed the villi that have the the sites on them. And also the Which I'm referring to gut organoids as well what we're doing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "The speaker expresses concurrence with a previous statement.",
                    "justification": "Yes, I would I would get I would agree with that."
                },
                {
                    "code_name": "differentiate",
                    "definition": "The speaker distinguishes between two or more things.",
                    "justification": "Not all organoids are the same."
                },
                {
                    "code_name": "provide example",
                    "definition": "The speaker offers a specific instance to illustrate a point.",
                    "justification": "such as the gut organoids are actually making real crips to feed the villi that have the the sites on them."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: Which I'm referring to gut organoids as well what we're doing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: But that was metabolism. Yeah yeah yeah don't don't don't expect them to actually have the right metabolism. That's just that's a big ask. It's surviving and making similar cell types is what we're looking for here. Um that's why I think people we should we should lower our standard a little bit because to expect a something in a dish to be an in vivo environment is never going to happen. In vivo like we can probably get there. In vivo you got to go into an animal for that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expresses Limitations",
                    "definition": "The speaker acknowledges the limitations or constraints of a particular approach or method.",
                    "justification": "The speaker expresses that expecting a certain level of metabolism in a dish (in vitro) is unrealistic, indicating an acknowledgment of limitations. Evidence: 'don't don't don't expect them to actually have the right metabolism. That's just that's a big ask.'"
                },
                {
                    "code_name": "Proposes Adjustment",
                    "definition": "The speaker suggests adjusting expectations, standards, or approaches.",
                    "justification": "The speaker thinks that standards should be lowered because expecting an in vitro environment to mimic an in vivo environment is unrealistic. Evidence: 'that's why I think people we should we should lower our standard a little bit'"
                },
                {
                    "code_name": "Compares Methods",
                    "definition": "The speaker compares different methods or approaches, in this case, in vitro vs. in vivo.",
                    "justification": "The speaker distinguishes between in vitro and in vivo environments, noting the limitations of each. Evidence: 'In vivo like we can probably get there. In vivo you got to go into an animal for that.'"
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers (UC Davis): I was going to mention the same paper. Although somebody commented that the mechanism of formation was different in vivo versus in the organoid, but that the function was similar. So I do think there are limitations. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "reference_shared_knowledge",
                    "definition": "Referencing a specific study or paper relevant to the discussion.",
                    "justification": "The speaker says, \"I was going to mention the same paper.\""
                },
                {
                    "code_name": "point_out_limitation",
                    "definition": "Highlighting potential issues or limitations in a study or approach.",
                    "justification": "The speaker mentions, \"So I do think there are limitations.\""
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers (UC Davis): But I think multi-disciplinary studies where you have people in vivo and you have organoids and then you are able to, I mean we can't study people, but you can do um patient specific therapeutics, right? So pulling cells or um or tumors out of patients to try to determine in their physiology if they can respond to these things. You kind of have to have all three because with without them you're you're running blind in some areas. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose_idea",
                    "definition": "Proposing a new method or approach.",
                    "justification": "The speaker suggests multi-disciplinary studies combining in vivo, organoids, and patient-specific therapeutics. 'But I think multi-disciplinary studies where you have people in vivo and you have organoids and then you are able to... You kind of have to have all three because without them you're you're running blind in some areas.'"
                },
                {
                    "code_name": "highlight_limitation",
                    "definition": "Mentioning constraints or drawbacks.",
                    "justification": "The speaker mentions the limitation of studying people directly. 'I mean we can't study people, but you can do um patient specific therapeutics, right?'"
                },
                {
                    "code_name": "emphasize_necessity",
                    "definition": "Emphasizing the need for something.",
                    "justification": "The speaker stresses the necessity of combining approaches. 'You kind of have to have all three because without them you're you're running blind in some areas.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle ASU: I think some of us are you can't study people though, right? Uh Molly, you study people, but what you get is not mechanistic per se. It's like a convolution of the mechanisms. And so there's got to be some I I I wish there is some translation between the mechanisms and the convolute the complex outputs of those mechanisms. And a lot of times that's things like blood flow because that's something you can see or biomarkers that are accessible, structural changes, um liquid biopsies, things like that that give you hints as to what the mechanism might be. But um so far uh those things have not been enough to give you a a strong inference of the mechanisms that are so have been so painstakingly acquired in in model systems. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Express Concern",
                    "definition": "The speaker expresses a concern or a limitation regarding the current state of research or a specific approach.",
                    "justification": "The speaker expresses concern about the limitations of studying people directly and the challenges in translating mechanisms from model systems to human studies. Evidence: 'I think some of us are you can't study people though, right? Uh Molly, you study people, but what you get is not mechanistic per se.'"
                },
                {
                    "code_name": "Propose Idea",
                    "definition": "The speaker suggests a potential solution or approach to a problem.",
                    "justification": "The speaker proposes considering alternative methods or indicators (like blood flow, biomarkers, structural changes, liquid biopsies) to infer mechanisms. Evidence: 'And a lot of times that's things like blood flow because that's something you can see or biomarkers that are accessible, structural changes, um liquid biopsies, things like that that give you hints as to what the mechanism might be.'"
                },
                {
                    "code_name": "Acknowledge Limitation",
                    "definition": "The speaker acknowledges a limitation or a challenge in their research or approach.",
                    "justification": "The speaker acknowledges that current methods have not been sufficient to strongly infer mechanisms from model systems. Evidence: 'But um so far uh those things have not been enough to give you a a strong inference of the mechanisms that are so have been so painstakingly acquired in in model systems.'"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: My lab's cheating a little bit. We are not looking at small molecules, we're looking at drugs. So we're trying to repurpose FDA approved drugs because I don't really develop drugs. Uh so that's that that's how we're skirting around this issue of like you develop a small molecule that's very effective in in vitro, you go into a patient doesn't it doesn't partition correctly in the body. What the heck's no, after 10 years of work, that's annoying. So we are we are we're cheating a little bit by uh just focusing right now on repurposing FDA approved drugs that have a huge literature. So the mechanism has been delved into in vitro, in animal models and in humans as much as we can. So um there's a way around that. Now, not every problem can, you know, uh we can't pull an FDA approved drug off the shelf for every single problem. That's not going to be feasible, but there's a good handful I think we can. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share_approach",
                    "definition": "The speaker describes their research method or approach.",
                    "justification": "The speaker explicitly mentions their lab's approach to repurposing FDA-approved drugs, 'My lab's cheating a little bit. We are not looking at small molecules, we're looking at drugs.'"
                },
                {
                    "code_name": "explain_challenge",
                    "definition": "The speaker discusses challenges or difficulties in their research.",
                    "justification": "The speaker mentions the challenge of developing small molecules that are effective in patients, 'you develop a small molecule that's very effective in in vitro, you go into a patient doesn't it doesn't partition correctly in the body.'"
                },
                {
                    "code_name": "propose_solution",
                    "definition": "The speaker suggests a solution or an alternative approach to a problem.",
                    "justification": "The speaker proposes repurposing FDA-approved drugs as a solution to the challenges of developing new drugs, 'So we are we are we're cheating a little bit by uh just focusing right now on repurposing FDA approved drugs that have a huge literature.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: So, so one of the issues is uh like I said before, is delivery and imaging that delivery. And I know that there's a maybe handful of drugs that allow for that. In fact, if I start scratching my head and trying to name one, I probably wouldn't be able to. Uh there's something on the pet side that's available, I think, but nowhere else. Do you think that this is a an important issue to be able to to see what you're delivering and where? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask_question",
                    "definition": "The speaker is posing a question to others, seeking their opinion or information.",
                    "justification": "The utterance ends with 'Do you think that this is a an important issue to be able to to see what you're delivering and where?' which is a clear question seeking opinions on the importance of delivery and imaging in drug administration."
                },
                {
                    "code_name": "express_uncertainty",
                    "definition": "The speaker is expressing uncertainty or lack of knowledge about something.",
                    "justification": "The speaker says 'In fact, if I start scratching my head and trying to name one, I probably wouldn't be able to,' indicating uncertainty about specific drugs that allow for delivery and imaging."
                },
                {
                    "code_name": "propose_topic_for_discussion",
                    "definition": "The speaker is introducing or suggesting a topic for discussion.",
                    "justification": "The speaker starts with 'So, so one of the issues is uh like I said before, is delivery and imaging that delivery,' which introduces the topic of delivery and imaging as an issue for discussion."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: I I can I can try to uh comment on that. I mean, I think the oldest uh sort of theranostic, maybe radioactive iodine for thyroid cancer. Because there you're getting a beta emission, which is killing the actual tumor and then or the thyroid in general and then you're also getting the uh gamma emission that you can detect with the camera. And so, um in my group, um you know, we've been interested in in uh well there's quite a there's quite a lot of efforts out there that are along these lines, especially the nanoparticle community, which can label, you know, things with both therapeutics and diagnostics. My group is stuck on the concept of uh reporter genes. And because GFP's been so critical to, you know, microscopy and biomedical applications and and study, you know, if we could develop good reporter genes for in vivo and human applications, that seems critically important to look at like living drug therapies. So cells that are being regenerative medicine for your cardiac myocytes or um you know, uh car T cells are a modern example, um virally delivered vectors another another example. And so, you know, to me on that front, if you can if you can image the delivery of these types of therapeutics that have different PK because they are tend to um sense and respond to pathology, that makes it a totally different problem than just what the admin characteristics are of a of uh chemotherapy or a biologic. So I think I think the idea is is ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Propose Idea",
                    "definition": "The speaker suggests a new concept or idea that could be explored or applied to a specific problem or field.",
                    "justification": "The speaker mentions, \"if we could develop good reporter genes for in vivo and human applications, that seems critically important to look at like living drug therapies.\""
                },
                {
                    "code_name": "Provide Information",
                    "definition": "The speaker shares knowledge or information relevant to the discussion, often providing background or context.",
                    "justification": "The speaker discusses theranostics, mentioning \"the oldest uh sort of theranostic, maybe radioactive iodine for thyroid cancer\" and explains its dual functionality."
                },
                {
                    "code_name": "Express Interest",
                    "definition": "The speaker expresses their interest or enthusiasm for a particular area of research or a specific idea.",
                    "justification": "The speaker notes, \"My group is stuck on the concept of uh reporter genes,\" showing their current focus and interest in this area."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: is really important and how do we develop things that are able to sense drug delivery. There's also the idea um from pet because I do pet on some of my day job that you can radio label the drug itself or something that's going to um show you whether or not you're inhibiting with therapeutic doses. So example of this is the estrogen receptor um and people have made drugs like full vestrant which are estrogen receptor degrader. So that drug binds to the estrogen receptor and it's got a hydrophobic group on it that targets the whole receptor to be degraded. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or approach to a problem.",
                    "justification": "The speaker proposes developing things that can sense drug delivery and mentions radio labeling drugs as an idea. Evidence: 'is really important and how do we develop things that are able to sense drug delivery. There's also the idea um from pet...'"
                },
                {
                    "code_name": "provide example",
                    "definition": "The speaker provides an example to illustrate a point or idea.",
                    "justification": "The speaker gives an example of estrogen receptor degraders like fulvestrant to explain how drugs can be designed to target specific receptors. Evidence: 'So example of this is the estrogen receptor um and people have made drugs like full vestrant which are estrogen receptor degrader.'"
                },
                {
                    "code_name": "share expertise",
                    "definition": "The speaker shares their knowledge or experience in a specific area.",
                    "justification": "The speaker mentions doing PET on some of their day job, indicating they are sharing their expertise. Evidence: 'There's also the idea um from pet because I do pet on some of my day job...'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Now if you make a estrogen receptor estradiol 4 and 18 probe, then you can use that to monitor the success of your estrogen receptor degrader in people. And so um people have have done this and it's becoming part of the standard of of drug development is try to try to develop companion diagnostic agents that are going to let you look at drug delivery and I'll stop. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new plan, method, or approach.",
                    "justification": "The speaker proposes developing a probe to monitor drug success: 'Now if you make a estrogen receptor estradiol 4 and 18 probe, then you can use that to monitor the success of your estrogen receptor degrader in people.'"
                },
                {
                    "code_name": "provide example",
                    "definition": "Giving a specific instance or illustration of a concept.",
                    "justification": "The speaker provides an example of an existing practice: 'people have have done this and it's becoming part of the standard of of drug development is try to try to develop companion diagnostic agents'."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, not not only drug delivery but also the the target engagement and dis disappearance of the target if that's the if that's the goal. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting additional aspects or ideas to consider in a discussion or project plan.",
                    "justification": "The utterance 'Well, not not only drug delivery but also the the target engagement and dis disappearance of the target if that's the if that's the goal.' shows Dr. Anna Moore expanding the scope of discussion to include target engagement and disappearance, indicating an additive or expansive proposal."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Um so so the word nano has been said several times. So um I I would like you guys to uh to give some thoughts about the future of nanotechnology in that regard. Um those of you who work in that area maybe want to speak a little bit. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or opinions on a particular topic.",
                    "justification": "The exact quote is 'give some thoughts about the future of nanotechnology in that regard.' This shows Dr. Moore is seeking thoughts or opinions on the topic."
                },
                {
                    "code_name": "invite contribution",
                    "definition": "The speaker is explicitly asking others to participate in the discussion, often based on their expertise.",
                    "justification": "The exact quote is 'Um those of you who work in that area maybe want to speak a little bit.' This indicates Dr. Moore is inviting contributions from specific participants."
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi, MSU: Yeah, before can I comment on that? So before going to nanotechnology, I just wanted to add one more thing and it's that like the problems of the in vitro make sense from different angles when you look at it. I mean from the like the biological point of view, it makes perfect sense that they don't basically recapitulate what happens in vivo. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "add_to_conversation",
                    "definition": "Adding a comment or thought to the conversation before proceeding.",
                    "justification": "The speaker requests to comment before moving on to a new topic, 'Yeah, before can I comment on that?'"
                },
                {
                    "code_name": "provide_expertise",
                    "definition": "Sharing knowledge or insights from one's area of expertise.",
                    "justification": "The speaker shares their understanding of the in vitro and in vivo contexts, 'I mean from the like the biological point of view, it makes perfect sense that they don't basically recapitulate what happens in vivo.'"
                },
                {
                    "code_name": "propose_collaboration",
                    "definition": "Suggesting that multiple researchers or experts work together.",
                    "justification": "The speaker suggests that a group of scientists with different perspectives collaborate, 'So I think for that purpose maybe a group of scientists that have different looks into the same problem needs to collaborate to each other to basically make a perfect in vitro like setting that can be more close to the in vivo part.'"
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi, MSU: But like from the physical point of view, it would be another story like different organs have different stiffness. They have like different properties and all of those things needs also to be considered in the in vitro setting. Like with the advances in the 3D bioprinting and like making like um uh pattern substrates that can basically provide opportunity for cells to basically make a 3D structures rather than like the flat surface uh 2D structured, all of those can be of a great help for getting more meaningful and robust in vitro data. So I think for that purpose maybe a group of scientists that have different looks into the same problem needs to collaborate to each other to basically make a perfect in vitro like setting that can be more close to the in vivo part. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker proposes an idea or suggests a approach.",
                    "justification": "The speaker suggests that 'a group of scientists that have different looks into the same problem needs to collaborate to each other to basically make a perfect in vitro like setting that can be more close to the in vivo part.' This indicates a proposal for collaboration to achieve a common goal. Quote: 'So I think for that purpose maybe a group of scientists that have different looks into the same problem needs to collaborate to each other to basically make a perfect in vitro like setting that can be more close to the in vivo part.'"
                },
                {
                    "code_name": "suggest solution",
                    "definition": "The speaker suggests a potential solution to a problem.",
                    "justification": "The speaker mentions that 'with the advances in the 3D bioprinting and like making like um uh pattern substrates that can basically provide opportunity for cells to basically make a 3D structures rather than like the flat surface uh 2D structured, all of those can be of a great help for getting more meaningful and robust in vitro data.' This suggests a potential solution to improve in vitro data. Quote: 'Like with the advances in the 3D bioprinting and like making like um uh pattern substrates that can basically provide opportunity for cells to basically make a 3D structures rather than like the flat surface uh 2D structured, all of those can be of a great help for getting more meaningful and robust in vitro data.'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: I'll just say on that that frame too like it's not only to just do the study if you could or study basic biology, if you can start making better 3D culture systems and start to grow organs, there's also huge biomedical applications and treatments that can come out of it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or approach for a project or research direction.",
                    "justification": "The speaker proposes expanding the research scope to include developing better 3D culture systems and growing organs for biomedical applications. Evidence: 'if you can start making better 3D culture systems and start to grow organs, there's also huge biomedical applications and treatments that can come out of it.'"
                },
                {
                    "code_name": "build upon previous idea",
                    "definition": "The speaker takes a previous idea and adds to it, expands on it, or suggests a new direction based on it.",
                    "justification": "The speaker is building upon a previous discussion (not directly coded but evident from context) about studying basic biology by suggesting an expansion into more applied research areas. Evidence: 'I'll just say on that that frame too like it's not only to just do the study if you could or study basic biology'"
                },
                {
                    "code_name": "highlight potential impact",
                    "definition": "The speaker emphasizes the potential benefits, applications, or positive outcomes of a proposed idea or research direction.",
                    "justification": "The speaker highlights the potential for 'huge biomedical applications and treatments' from their proposed idea. Evidence: 'there's also huge biomedical applications and treatments that can come out of it.'"
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi, MSU: Yeah, exactly. These are basically the concept of the lab on a chip which basically again it's a kind of multidisciplinary thing. And for the nanotechnology, I mean, we are working in the field of nanomedicine for a couple of years and like one of the main problems that we have for delivery and also for like using them as a contrast agent is their interactions with biological systems. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share knowledge",
                    "definition": "The speaker is sharing information or expertise related to the topic of discussion.",
                    "justification": "The speaker mentions their work in the field of nanomedicine and a specific problem they are facing, \"we are working in the field of nanomedicine for a couple of years and like one of the main problems that we have for delivery and also for like using them as a contrast agent is their interactions with biological systems.\""
                },
                {
                    "code_name": "describe research",
                    "definition": "The speaker is describing their research or area of work.",
                    "justification": "The speaker explains the concept of \"lab on a chip\" and their work with nanotechnology, \"These are basically the concept of the lab on a chip which basically again it's a kind of multidisciplinary thing.\""
                },
                {
                    "code_name": "identify challenge",
                    "definition": "The speaker is pointing out a challenge or problem in their research area.",
                    "justification": "The speaker identifies a main problem in using nanotechnology, specifically \"their interactions with biological systems.\""
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi, MSU: So what happens is that what we makes in like laboratories are totally different from what we see like when they interact with the plasma proteins or any type of biological fluids. So what happens is that different types of biomolecules comes to the surface of nanoparticles and interact with them and basically form a corona around the surface of nanoparticles. So based on the type of the proteins, amount of the proteins, conformational changes of the proteins, basically we have totally different fate for the nanoparticles. So it can affect imaging, it can affect targeting, it can affect safety of the nanoparticles and those things basically needs to be considered in the imaging like procedures because you can imagine when you have additional layer at the surface of like nanoparticles, if you use that nanoparticles as a carrier, so what happens is that they can affect drug release. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "explain_phenomenon",
                    "definition": "Providing a detailed description of how something works or happens.",
                    "justification": "The speaker provides a detailed explanation of the interaction between nanoparticles and biological systems: \"So what happens is that what we makes in like laboratories are totally different from what we see like when they interact with the plasma proteins or any type of biological fluids.\""
                },
                {
                    "code_name": "identify_challenge",
                    "definition": "Pointing out difficulties or obstacles in a process or situation.",
                    "justification": "The speaker identifies challenges in using nanoparticles: \"So it can affect imaging, it can affect targeting, it can affect safety of the nanoparticles\""
                },
                {
                    "code_name": "suggest_consideration",
                    "definition": "Proposing that something should be taken into account.",
                    "justification": "The speaker suggests considering factors in imaging procedures: \"and those things basically needs to be considered in the imaging like procedures\""
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi, MSU: Or if you have like a fluorophore or something like that and what happens is that we may have like some unwanted interactions with those like labeling species that can affect the like the imaging capacity. So from a nanotechnology perspective, I would say we need more information about like the protein corona and how it can affect the safety and biological like fate of nanoparticles. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a consideration or a potential issue that needs to be addressed.",
                    "justification": "The speaker mentions, \"Or if you have like a fluorophore or something like that and what happens is that we may have like some unwanted interactions with those like labeling species that can affect the like the imaging capacity.\" This indicates a suggestion of a problem that needs consideration."
                },
                {
                    "code_name": "request info",
                    "definition": "The speaker asks for more information or clarification on a specific topic.",
                    "justification": "The speaker says, \"So from a nanotechnology perspective, I would say we need more information about like the protein corona and how it can affect the safety and biological like fate of nanoparticles.\" This directly indicates a request for information."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos, UCSD: So maybe also to follow up on Morteza's point um so in my research I focus a little bit more on using nanotechnology to manipulate the light. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "build_on_others",
                    "definition": "The speaker is acknowledging and expanding on a previous point made by another participant.",
                    "justification": "The speaker starts with 'So maybe also to follow up on Morteza's point,' which directly references and builds upon Morteza's previous statement."
                },
                {
                    "code_name": "share_research",
                    "definition": "The speaker is sharing their research focus or area of expertise.",
                    "justification": "The speaker mentions, 'in my research I focus a little bit more on using nanotechnology to manipulate the light,' which clearly states their research focus."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos, UCSD: So I think there is there's the whole field of you know, having nanoparticles in the body and and Morteza really nicely outlined also several of the challenges that come with that. Um and I think some of uh you know, what I think is kind of a new direction in using nanotechnology is actually um not necessarily having it interact directly in the body but having it manipulate the light with which you illuminate uh the part the biological species you want to see and actually then using light itself as a marker. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new approach or perspective.",
                    "justification": "The speaker proposes a new direction in using nanotechnology for manipulating light to illuminate biological species: '...not necessarily having it interact directly in the body but having it manipulate the light with which you illuminate uh the part the biological species you want to see and actually then using light itself as a marker.'"
                },
                {
                    "code_name": "reference previous work/ideas",
                    "definition": "The speaker references or builds upon previous discussions or ideas.",
                    "justification": "The speaker references Morteza's previous points: 'Morteza really nicely outlined also several of the challenges that come with that.'"
                },
                {
                    "code_name": "seek perspectives/information",
                    "definition": "The speaker asks for others' opinions or information.",
                    "justification": "The speaker seeks perspectives on imaging the extracellular matrix: 'So um I'm curious to know how do people image that today because I think using sophisticated nano optics it would be potentially possible to monitor that.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos, UCSD: Um and some of the things I I'd also love to get people's perspective on there is um for example also as Morteza was saying, there are new ways where you can better um model the tissue in three dimensions and actually get effects such as the extracellular matrix um and and for instance in breast cancer metastasis, the extracellular matrix actually plays a really critical role. So um I'm curious to know how do people image that today because I think using sophisticated nano optics it would be potentially possible to monitor that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker seeks information or opinions from others.",
                    "justification": "So um I'm curious to know how do people image that today"
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker presents a potential solution or approach.",
                    "justification": "I think using sophisticated nano optics it would be potentially possible to monitor that."
                },
                {
                    "code_name": "reference previous speaker",
                    "definition": "The speaker mentions or builds upon something said by another speaker.",
                    "justification": "as Morteza was saying"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: It's a great question how to image the matrix. There aren't great tools as I understand. Maybe someone else knows. I think there's some MR techniques and someone MR might be Molly can jump in and correct me but I think there are ways to look at like higher how hyaluronic acid or you know, things that are around but I I don't know too much that's um specific to ECM like imaging collagen. I mean, I guess the other other techniques that come to mind are like MR elastography that's like Yeah and and ultrasound sort of stiffness measurements. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "request info",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The speaker starts with 'It's a great question how to image the matrix. There aren't great tools as I understand. Maybe someone else knows.'"
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a potential solution or idea.",
                    "justification": "The speaker mentions specific techniques like 'MR techniques,' 'MR elastography,' and 'ultrasound sort of stiffness measurements' as potential ways to address the issue."
                },
                {
                    "code_name": "invite contribution",
                    "definition": "The speaker invites others to share their knowledge or opinions.",
                    "justification": "The speaker says, 'Maybe someone else knows,' and 'Molly can jump in and correct me,' which are clear invitations for others to contribute."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Just some extent you oh go ahead. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "let speak",
                    "definition": "Yielding the floor to someone else, inviting them to speak or proceed.",
                    "justification": "The utterance 'Just some extent you oh go ahead.' includes 'go ahead,' which invites someone to proceed with their thoughts."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Talk to me. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: I was just going to say that, you know, perfusion and diffusion imaging goes this it's in the same category. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "add information",
                    "definition": "The speaker provides additional information relevant to the conversation.",
                    "justification": "Dr. Moore adds new information by mentioning 'perfusion and diffusion imaging'."
                },
                {
                    "code_name": "connect ideas",
                    "definition": "The speaker explicitly relates their point to previous or related ideas.",
                    "justification": "Dr. Moore indicates her point is related to previous discussion with 'I was just going to say that'."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle, ASU: Well, to some extent you can use MRscopy. Um people have picked up hyaluronic acid that way, but it's only for things that are highly um highly present there. So what is the signaling space of the ECM, what kind of cytokines have been decorating the ECM, all that stuff is kind of beyond the reach of clinical imaging without a biopsy. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "suggest method",
                    "definition": "The speaker suggests using a particular method or technique.",
                    "justification": "Well, to some extent you can use MRscopy."
                },
                {
                    "code_name": "ask question",
                    "definition": "The speaker seeks information or clarification.",
                    "justification": "So what is the signaling space of the ECM, what kind of cytokines have been decorating the ECM"
                },
                {
                    "code_name": "provide info",
                    "definition": "The speaker shares knowledge or facts.",
                    "justification": "Um people have picked up hyaluronic acid that way, but it's only for things that are highly um highly present there"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, lactate. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Acknowledge or show agreement with a previous statement.",
                    "justification": "The utterance 'Yeah, lactate.' is a brief acknowledgement of a previous statement, likely in response to Benjamin Bartelle's mention of 'hyaluronic acid' and 'lactate' being detectable through certain imaging methods. The verbatim quote is 'Yeah, lactate.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Yeah, I mean, I I think like as a big field a big wide open blue ocean of research really is the extracellular space because we know so much about cell biology, but like we don't really even know what happens to proteins very well once they get in the extracellular space, especially in the animal. So uh and it's very it's a challenging field, right? Because it's hard to um model that in in as we got this comes full circle back to the culture conditions question. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a suggestion or concept for discussion or consideration.",
                    "justification": "The speaker proposes the extracellular space as a 'big wide open blue ocean of research' and highlights its potential for investigation. Evidence: 'I think like as a big field a big wide open blue ocean of research really is the extracellular space'."
                },
                {
                    "code_name": "identify challenge",
                    "definition": "Pointing out a difficulty or obstacle related to the discussion topic.",
                    "justification": "The speaker notes that the field is 'challenging' and explains why, citing the difficulty of modeling the extracellular space. Evidence: 'So uh and it's very it's a challenging field, right? Because it's hard to um model that in in as we got this comes full circle back to the culture conditions question.'"
                },
                {
                    "code_name": "connect idea to previous discussion",
                    "definition": "Linking a current idea to a previously discussed topic.",
                    "justification": "The speaker references the 'culture conditions question' which was presumably discussed earlier, showing an attempt to connect their idea to previous conversation. Evidence: 'as we got this comes full circle back to the culture conditions question.'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Tough. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express_difficulty",
                    "definition": "The speaker is expressing that something is challenging or hard to achieve or understand.",
                    "justification": "The utterance 'Tough.' suggests that the speaker finds the topic or situation being discussed to be difficult or challenging."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay, so I I think that uh at the end of this um at the end of the session we will need to produce some ",
        "annotations": {
            "codes": [
                {
                    "code_name": "set goal",
                    "definition": "Setting a goal or expectation for future collaboration or output.",
                    "justification": "The speaker, Dr. Anna Moore, mentions 'at the end of this um at the end of the session we will need to produce some', indicating a goal for the session's outcome."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: ideas and some hard pressing questions, uh what is on the way from translating things um from models to humans. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a topic or concept for consideration or discussion.",
                    "justification": "The utterance starts with 'ideas and some hard pressing questions,' which indicates Dr. Anna Moore is introducing topics for discussion. Evidence: 'ideas and some hard pressing questions'"
                },
                {
                    "code_name": "ask question",
                    "definition": "Seeking information or clarification through a query.",
                    "justification": "The phrase 'what is on the way from translating things um from models to humans' is a question about the process or challenges in translation. Evidence: 'what is on the way from translating things um from models to humans'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Um in in all those various areas, not just, you know, drug delivery but just imaging. Even translating imaging agents uh that also requires some jumping through the loops. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting new areas or ideas for research.",
                    "justification": "The speaker suggests considering 'not just, you know, drug delivery but just imaging.'"
                },
                {
                    "code_name": "identify challenge",
                    "definition": "Pointing out difficulties or obstacles in the research.",
                    "justification": "The speaker notes 'that also requires some jumping through the loops.' indicating a challenge."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You | MIT: Yeah, I'm really curious to know like um why why it takes 10 years, this is a very naive question. Why it takes 10 years to develop drugs and uh why it takes uh thousands of millions. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The speaker asks, \"why it takes 10 years to develop drugs and uh why it takes uh thousands of millions.\" This shows a clear attempt to seek information."
                },
                {
                    "code_name": "express curiosity",
                    "definition": "The speaker expresses a desire to know more about something.",
                    "justification": "The speaker says, \"I'm really curious to know,\" which directly indicates curiosity."
                },
                {
                    "code_name": "self-deprecating remark",
                    "definition": "The speaker makes a remark that downplays their own question or idea, often to show humility.",
                    "justification": "The speaker mentions, \"this is a very naive question,\" which is a self-deprecating remark to potentially soften the perception of their inquiry."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: I guess how much clinicians get paid, it's uh, you know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express uncertainty",
                    "definition": "The speaker expresses uncertainty or hesitation about a topic.",
                    "justification": "The speaker says 'I guess how much clinicians get paid, it's uh, you know.' The use of 'I guess' and 'uh' indicates uncertainty."
                },
                {
                    "code_name": "self-disclose",
                    "definition": "The speaker shares personal information about themselves.",
                    "justification": "The speaker says 'As the clinician on the call, I can't defend anything here...' which reveals their profession and position in the discussion."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Okay. Sorry guys, it's a big part of it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "The speaker acknowledges a point or situation, showing awareness or acceptance.",
                    "justification": "The phrase 'Okay. Sorry guys, it's a big part of it.' indicates acknowledgment and a hint of apology for something being a significant aspect."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: As the as the clinician on the call, I can't defend anything here, but I guess the um, the the thing that strikes me is is the sheer just amount of research that needs to go in to validate safety and the amount of time that that takes and effort. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "The speaker expresses worry about the amount of research needed and the time it takes.",
                    "justification": "The speaker mentions 'the sheer just amount of research that needs to go in to validate safety and the amount of time that that takes and effort.'"
                },
                {
                    "code_name": "acknowledge limitation",
                    "definition": "The speaker acknowledges their limitation in contributing to the discussion.",
                    "justification": "The speaker says, 'As the clinician on the call, I can't defend anything here,'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: And then doing, you know, to get something to as an imaging probe, it's actually frankly somewhat markedly easier to get into the clinic than it is for a therapeutic where imaging probes generally are benign, right? They're not going to kill you, a radio tracer is low, MR contrast agents may be harder. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide explanation",
                    "definition": "Providing information to make something clear or understandable.",
                    "justification": "The speaker explains why imaging probes are easier to get into the clinic, e.g., 'it's actually frankly somewhat markedly easier to get into the clinic than it is for a therapeutic where imaging probes generally are benign, right?'"
                },
                {
                    "code_name": "compare",
                    "definition": "Identifying similarities or differences between two or more things.",
                    "justification": "The speaker compares getting imaging probes into the clinic versus therapeutics, e.g., 'And then doing, you know, to get something to as an imaging probe, it's actually frankly somewhat markedly easier to get into the clinic than it is for a therapeutic...'"
                },
                {
                    "code_name": "offer justification",
                    "definition": "Giving reasons or evidence to support a statement.",
                    "justification": "The speaker justifies the comparison by explaining the nature of imaging probes, e.g., 'They're not going to kill you, a radio tracer is low, MR contrast agents may be harder.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Somehow we've convinced people of this. Yeah, it's amazing. But yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge_achievement",
                    "definition": "The speaker acknowledges a collective achievement or success.",
                    "justification": "The phrase 'Somehow we've convinced people of this' implies a collective effort to convince others, which is being acknowledged."
                },
                {
                    "code_name": "express_surprise",
                    "definition": "The speaker expresses surprise or astonishment at something.",
                    "justification": "The phrase 'Yeah, it's amazing' directly indicates surprise or amazement."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, yeah, because, you know, radio tracer, you inject them in such a small, small quantity that, you know, it's. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide_explanation",
                    "definition": "The act of explaining or describing something.",
                    "justification": "Dr. Anna Moore provides an explanation for the safety or usage of radio tracers by mentioning the small quantity injected, 'Well, yeah, because, you know, radio tracer, you inject them in such a small, small quantity that, you know, it's.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Oh yeah, I'm talking about Gadolinium. That's just. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, Gadolinium. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: It's some reason it's okay to put in millimolar amounts of Gadolinium into a person. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "Expressing worry or disapproval about a particular action or situation.",
                    "justification": "The utterance expresses concern about putting 'millimolar amounts of Gadolinium into a person', implying a worry about safety or ethical standards. Evidence: 'It's some reason it's okay to put in millimolar amounts of Gadolinium into a person.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, there's a warning on the label. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "Acknowledge or concede a point made by someone else.",
                    "justification": "The utterance 'Well, there's a warning on the label.' acknowledges Benjamin Bartelle's concern about Gadolinium, implying that there is a warning label, thus showing awareness of the issue."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: The debate the debate rages, yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge debate",
                    "definition": "The speaker acknowledges or comments on an ongoing debate or controversy.",
                    "justification": "The phrase 'The debate... rages' directly references an ongoing debate, showing the speaker's acknowledgment of it. ('The debate the debate rages, yeah.')"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: But but I think, you know, the therapeutic index for a therapy is a huge deal, right? If you you don't want to be causing toxicity and in the realm of do no harm, right? It it just takes us. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "Expressing a concern or a potential issue related to the discussion topic.",
                    "justification": "The speaker expresses concern about causing toxicity, quoting 'If you you don't want to be causing toxicity and in the realm of do no harm'. This indicates a careful consideration of potential negative consequences."
                },
                {
                    "code_name": "invoke principle",
                    "definition": "Invoking a general principle or concept relevant to the discussion.",
                    "justification": "The speaker invokes the principle of 'do no harm', quoting 'in the realm of do no harm'. This suggests that the speaker is guided by a general ethical principle in their consideration."
                },
                {
                    "code_name": "highlight importance",
                    "definition": "Highlighting the importance of a particular aspect or consideration.",
                    "justification": "The speaker highlights the importance of the therapeutic index, stating 'the therapeutic index for a therapy is a huge deal'. This emphasizes the speaker's perception of the significance of this factor."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: So so Sian, I I I don't know how to answer the question other than to say like as imagers, we actually are in a better position of um, getting things translated. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide expertise",
                    "definition": "The speaker provides their expertise or perspective as a specialist in a particular area.",
                    "justification": "The speaker mentions 'as imagers, we actually are in a better position of um, getting things translated.' This indicates that they are providing their expertise as imagers. The quote 'as imagers' highlights their specialized perspective."
                },
                {
                    "code_name": "hedge",
                    "definition": "The speaker expresses uncertainty or hesitation in their statement.",
                    "justification": "The speaker says 'I I I don't know how to answer the question other than to say like...'. The use of 'I don't know' and 'like' indicates hesitation and uncertainty."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: So like, you know, this was there's image guided therapies being here. People have developed fluorescent probes to thing like folate receptor or looking at um ICG for various lung cancers. So people have taken, you know, molecular imaging approaches and put those into patients without a huge, you know, long, long time to get those um, we're talking years rather than 10 years maybe to do this. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a concept, approach, or perspective for consideration.",
                    "justification": "The speaker suggests a viewpoint on the efficiency of developments: 'So people have taken, you know, molecular imaging approaches and put those into patients without a huge, you know, long, long time to get those um, we're talking years rather than 10 years maybe to do this.'"
                },
                {
                    "code_name": "provide information",
                    "definition": "Sharing knowledge or data.",
                    "justification": "The speaker shares specific information about developments: 'People have developed fluorescent probes to thing like folate receptor or looking at um ICG for various lung cancers.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, but you know, answering your question uh Sian is um, you know, just just look at the catalog from uh Charles River, you know, how much you pay for a transgenic animal. You know, it's like 250 bucks for one mouse. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide information",
                    "definition": "The speaker offers data or facts relevant to the discussion.",
                    "justification": "Dr. Anna Moore provides specific information about the cost of transgenic animals from Charles River, saying \"just just look at the catalog from uh Charles River, you know, how much you pay for a transgenic animal. You know, it's like 250 bucks for one mouse.\""
                },
                {
                    "code_name": "answer question",
                    "definition": "The speaker is providing a response to a question posed by another participant.",
                    "justification": "Dr. Anna Moore starts her utterance with \"Well, but you know, answering your question uh Sian,\" indicating she is directly responding to Sian's question."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: That's a deal. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: We transgenic GQ animals, 400 bucks anyway. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: I know. I'm with you, I'm with you. I know. And yeah, those are even higher. And then you need n equals more than three, right? To do anything, you know, anything meaningful. And then um, all the antibodies and everything, and then once you're done with the with the with the pre-clinical studies in your lab. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Showing agreement with a previous statement.",
                    "justification": "The speaker says 'I know. I'm with you, I'm with you. I know.' which indicates agreement."
                },
                {
                    "code_name": "discuss_methodology",
                    "definition": "Discussing the methodology or requirements for a study.",
                    "justification": "The speaker mentions 'And then you need n equals more than three, right? To do anything, you know, anything meaningful.'"
                },
                {
                    "code_name": "outline_research_steps",
                    "definition": "Outlining steps involved in the research process.",
                    "justification": "The speaker outlines steps by mentioning 'And then um, all the antibodies and everything, and then once you're done with the with the with the pre-clinical studies in your lab.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: You go to CROs, uh, which are contract research organizations to do tox, to do PKPD, that's all required by FDA. And I hate to show you the bills from those companies because I went through that with my uh, with the compound that we're developed. You just, you know, basically wondering, you know, how can you possibly pay for all that? So, and then, uh, the companies that, you know, they invest money in this and then they want to recover those money and then we're wondering why the drugs are so expensive because if so much money you want to recover it somehow, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share_experience",
                    "definition": "The speaker shares personal experience related to the discussion topic.",
                    "justification": "Dr. Anna Moore shares her experience with the costs associated with contract research organizations (CROs) and the financial implications of drug development. Evidence: \"I hate to show you the bills from those companies because I went through that with my uh, with the compound that we're developed.\""
                },
                {
                    "code_name": "express_concern",
                    "definition": "The speaker expresses worry or concern about a topic being discussed.",
                    "justification": "Dr. Anna Moore expresses concern about the high costs of using CROs and the subsequent high drug prices. Evidence: \"You just, you know, basically wondering, you know, how can you possibly pay for all that?\""
                },
                {
                    "code_name": "explain",
                    "definition": "The speaker provides information or explanations about a topic.",
                    "justification": "Dr. Anna Moore explains why drugs are expensive, linking it to the investment by companies and their need to recover those investments. Evidence: \"So, and then, uh, the companies that, you know, they invest money in this and then they want to recover those money and then we're wondering why the drugs are so expensive because if so much money you want to recover it somehow, right?\""
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: There's a ray of light. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express optimism",
                    "definition": "Expressing a positive outlook or hope regarding the discussion topic.",
                    "justification": "The phrase 'There's a ray of light' is a clear expression of optimism. Quote: 'There's a ray of light.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: And that this builds on something Dylan brought up earlier is um, you were saying you're using clinically approved drugs in your your studies and that sort of gives you a shortcut, right? With the 90% of investment in new medicines is in biologic drugs. Most of these are antibody based drugs, right? And they're going after specific targets. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "build_on_others_ideas",
                    "definition": "Building on or referencing others' ideas or previous discussions.",
                    "justification": "The utterance starts with 'And that this builds on something Dylan brought up earlier', indicating that Benjamin Bartelle is building on a previous idea. The exact quote is: 'And that this builds on something Dylan brought up earlier'."
                },
                {
                    "code_name": "ask_question",
                    "definition": "Asking a question to clarify or seek information.",
                    "justification": "The utterance contains a question: 'that sort of gives you a shortcut, right?' and 'Most of these are antibody based drugs, right?'. These questions seek confirmation or clarification."
                },
                {
                    "code_name": "provide_information",
                    "definition": "Sharing information or facts to educate or inform others.",
                    "justification": "The utterance provides information about the investment in new medicines and the types of drugs being developed: 'With the 90% of investment in new medicines is in biologic drugs. Most of these are antibody based drugs, right? And they're going after specific targets.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Like I made an antibody against this target, antibody against that target, I've proved that it's focal enough where it doesn't cause the worst side effects. Because of the modularity of nanotechnology and biological systems, the what everyone is doing right now, at least in the synthetic biology space, is they're starting with that. like we know this biologic drug hits this target safely. And so now we're going to build a car T cell therapy around that biologic drug. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share knowledge",
                    "definition": "The speaker shares their expertise or knowledge on a specific topic.",
                    "justification": "The speaker shares their experience with antibodies, stating 'Like I made an antibody against this target, antibody against that target, I've proved that it's focal enough where it doesn't cause the worst side effects.'"
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new idea or approach.",
                    "justification": "The speaker proposes building a CAR T cell therapy around a biologic drug, stating 'like we know this biologic drug hits this target safely. And so now we're going to build a car T cell therapy around that biologic drug.'"
                },
                {
                    "code_name": "describe methodology",
                    "definition": "The speaker explains a research method or approach.",
                    "justification": "The speaker describes the current approach in the synthetic biology space, stating 'Because of the modularity of nanotechnology and biological systems, the what everyone is doing right now, at least in the synthetic biology space, is they're starting with that.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: We know that this drug goes hits T cells specifically. Great, we're building a theragnostic that's going to find the T cells and report back to us that it's done a job in it. So we have there is a way of bypassing some of that initial safety testing if you do go with these um biologics or just antibodies that are already approved. So there there's some hope there and I think the as we get better and better at this, we may start building out something like a grass list, you know, it's like generally recognized as safe list. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new concept or approach.",
                    "justification": "The speaker proposes the idea of building a 'generally recognized as safe list' (akin to a 'grass list') for biologics or antibodies that are already approved, suggesting a new approach to safety testing. Evidence: 'So there there's some hope there and I think the as we get better and better at this, we may start building out something like a grass list, you know, it's like generally recognized as safe list.'"
                },
                {
                    "code_name": "share knowledge",
                    "definition": "The speaker provides information or insights relevant to the discussion.",
                    "justification": "The speaker shares specific knowledge about the drug hitting T cells specifically and the potential for bypassing initial safety testing with approved biologics or antibodies. Evidence: 'We know that this drug goes hits T cells specifically.'"
                },
                {
                    "code_name": "express optimism",
                    "definition": "The speaker expresses a positive outlook or hope regarding the discussed topic.",
                    "justification": "The speaker expresses hope regarding the potential for improving safety testing and the development of new approaches. Evidence: 'So there there's some hope there'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Good points. ",
        "annotations": {
            "code_name": "none"
        }
    },
    {
        "utterance": "Dr. Anna Moore: But but I'm still wondering if, you know, wouldn't it be great if every single drug that you uh inject has somewhat some kind of an image image guided guidance image guiding properties. So you can monitor this drug. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new concept or approach.",
                    "justification": "The utterance proposes integrating image-guided properties into drugs for monitoring purposes. Quote: 'wouldn't it be great if every single drug that you uh inject has somewhat some kind of an image image guided guidance image guiding properties. So you can monitor this drug.'"
                },
                {
                    "code_name": "express wonder",
                    "definition": "The speaker expresses curiosity or wonder about a topic.",
                    "justification": "The speaker starts with 'But but I'm still wondering if', indicating curiosity. Quote: 'But but I'm still wondering if'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Uh, without sacrificing, you know, many, many animals. And avoiding those costly studies that you have to pay for because you can actually do it yourself. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Propose idea",
                    "definition": "The speaker is suggesting a new idea or approach.",
                    "justification": "The utterance implies an idea for reducing animal sacrifice and costs in research. The verbatim quote that supports this is 'without sacrificing, you know, many, many animals. And avoiding those costly studies.'"
                },
                {
                    "code_name": "Express concern",
                    "definition": "The speaker is expressing worry or concern about a particular issue.",
                    "justification": "The speaker expresses concern about sacrificing 'many, many animals,' which indicates a worry about animal welfare. The exact quote is 'without sacrificing, you know, many, many animals.'"
                },
                {
                    "code_name": "Suggest efficiency",
                    "definition": "The speaker is suggesting a way to make a process more efficient or cost-effective.",
                    "justification": "The utterance includes 'avoiding those costly studies that you have to pay for because you can actually do it yourself,' which suggests a strategy for reducing costs. The verbatim quote supporting this is 'avoiding those costly studies that you have to pay for because you can actually do it yourself.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Because you can get quantitative data. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide rationale",
                    "definition": "Providing a reason or explanation to support a statement.",
                    "justification": "The speaker provides a reason for their previous statement about image-guided guidance. Quote: 'Because you can get quantitative data.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: So what I'm hearing is that uh, so for therapies, the major barrier is actually in biology is in in the therapies. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "summarize",
                    "definition": "Summarize the main point or key takeaway from the discussion.",
                    "justification": "The speaker is summarizing the main point from the previous discussion, 'So what I'm hearing is that uh, so for therapies, the major barrier is actually in biology is in in the therapies.' The verbatim quote 'So what I'm hearing' indicates a summarization of previous discussion."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: It's not image guiding technologies. But if we want to develop image guiding technologies, it will be helpful to develop something that can monitor these early changes induced by the drugs. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Proposing a new idea or suggestion.",
                    "justification": "The speaker proposes developing something to monitor early changes induced by drugs, as evidenced by the quote 'it will be helpful to develop something that can monitor these early changes induced by the drugs.'"
                },
                {
                    "code_name": "build on previous idea",
                    "definition": "Building on or responding to a previous idea or suggestion.",
                    "justification": "The speaker references a previous discussion about image guiding technologies, as evidenced by the quote 'if we want to develop image guiding technologies'."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: So either is the delivery of the. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: With companion diagnostics. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "add_info",
                    "definition": "Providing additional information to the conversation.",
                    "justification": "The utterance 'With companion diagnostics.' provides additional information to the conversation, likely related to the previous discussion about therapies or image guiding technologies. The context suggests that Dr. Anna Moore is contributing to the discussion by mentioning companion diagnostics."
                },
                {
                    "code_name": "build_on_idea",
                    "definition": "Adding to or expanding on a previously mentioned idea.",
                    "justification": "The utterance 'With companion diagnostics.' seems to be building on a previous idea related to developing image guiding technologies or therapies. The context suggests that Dr. Anna Moore is contributing to the discussion by mentioning companion diagnostics, which is likely related to the previous conversation about monitoring early changes induced by drugs."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Companion diagnostics. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: Can I weigh in on a completely different take on on I guess yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "request_to_contribute",
                    "definition": "The speaker requests to share their thoughts or opinions on the topic.",
                    "justification": "The speaker says 'Can I weigh in on a completely different take' indicating they want to contribute to the discussion. The exact quote is 'Can I weigh in on a completely different take'."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: So I think about it from the other end and I guess I'm surrounded by very long-term treatments and also ambiguous treatments. So there are so many therapeutics and drugs that we use in humans that may or may not work for someone, we don't know how to dose it and we don't have an imaging marker of what it's doing particularly in the brain. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share_perspective",
                    "definition": "Sharing personal viewpoint.",
                    "justification": "The speaker shares her viewpoint by stating, 'So I think about it from the other end and I guess I'm surrounded by very long-term treatments and also ambiguous treatments.'"
                },
                {
                    "code_name": "identify_challenge",
                    "definition": "Pointing out challenges or problems.",
                    "justification": "The speaker identifies challenges by mentioning, 'So there are so many therapeutics and drugs that we use in humans that may or may not work for someone, we don't know how to dose it and we don't have an imaging marker of what it's doing particularly in the brain.'"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: Um, so that's that's my domain would be the brain, that's unfortunately what I can focus on. But there are so many drugs that I think sit into this category and if you think of all of the mood disorders and anything to do with mental health, anything to do with long-term degeneration of neural function uh and and dementia. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Introduce Domain",
                    "definition": "The speaker introduces or specifies their area of expertise or focus.",
                    "justification": "The speaker, Molly Bright, explicitly states her domain as the brain, indicating her area of focus. Quote: 'Um, so that's that's my domain would be the brain'"
                },
                {
                    "code_name": "Propose Idea/Broaden Discussion",
                    "definition": "The speaker suggests expanding the discussion or proposes an idea to consider.",
                    "justification": "Molly Bright mentions numerous drugs that could fit into a certain category and relates it to mood disorders, mental health, and neural degeneration, broadening the discussion. Quote: 'But there are so many drugs that I think sit into this category and if you think of all of the mood disorders and anything to do with mental health, anything to do with long-term degeneration of neural function uh and and dementia.'"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: We need a time scale of looking at. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express need",
                    "definition": "The speaker is expressing a requirement or necessity for something.",
                    "justification": "The phrase 'We need' directly indicates a necessity. The exact quote is 'We need a time scale of looking at. '"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: What a drug does and what happens in the absence of that drug in the face of huge human variability to evaluate if we're remotely close to getting after what we're after. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker is suggesting a way to approach a problem or idea.",
                    "justification": "The utterance proposes a way to evaluate the effectiveness of a drug, specifically 'What a drug does and what happens in the absence of that drug in the face of huge human variability to evaluate if we're remotely close to getting after what we're after.' The verbatim quote is the entire utterance."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: And that is a huge cost. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge tone",
                    "definition": "Acknowledging the tone or potential impact of one's previous statement.",
                    "justification": "The utterance 'Sorry, downer.' acknowledges the potentially negative tone of the previous statement. The verbatim quote is 'Sorry, downer.'"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: Sorry, downer. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge limitation",
                    "definition": "The speaker acknowledges a limitation or a potentially discouraging aspect of their research or proposal.",
                    "justification": "The utterance 'Sorry, downer. ' implies that Molly Bright recognizes her previous comments might have been discouraging or negative ('downer'). The use of 'Sorry' indicates an acknowledgment of potentially impacting the group's mood negatively."
                },
                {
                    "code_name": "express concern",
                    "definition": "The speaker expresses worry or concern about the discussion or project.",
                    "justification": "By calling herself a 'downer,' Molly Bright expresses concern that her input might have been too negative or problematic."
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Well, I don't know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express uncertainty",
                    "definition": "The speaker expresses doubt or uncertainty about the topic.",
                    "justification": "The speaker says 'Well, I don't know.' which indicates uncertainty. The exact quote is 'Well, I don't know.'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Is hyperpolarized a way forwards to look at function in the brain using hyperpolarized substrates with MRI? ",
        "annotations": {
            "code_name": "none"
        }
    },
    {
        "utterance": "Molly Bright: Is that really going to get at the. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is posing a question to seek information or clarification.",
                    "justification": "The utterance 'Is that really going to get at the. .' is clearly a question, as evidenced by the question mark and the structure of the sentence, indicating Molly Bright is seeking more information."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: The limitation of this scale of treatment efficacy? Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The utterance starts with 'The limitation of this scale of treatment efficacy? Yeah.', where 'The limitation...' is a clear inquiry. Quote: 'The limitation of this scale of treatment efficacy?'"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Right. So so efficacy as measured by some um, for psychiatric disease. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "mark sellmyer: Really hard to measure, well, harder to measure than let's say a tumor size, you know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "expresses challenge",
                    "definition": "The speaker mentions a difficulty or a problem related to the topic of discussion.",
                    "justification": "The utterance explicitly mentions a challenge in measuring the efficacy of treatments. The verbatim quote is 'Really hard to measure'."
                },
                {
                    "code_name": "compares",
                    "definition": "The speaker makes a comparison between two or more things to highlight differences or similarities.",
                    "justification": "The comparison is made between the difficulty of measuring psychiatric disease treatment efficacy and measuring tumor size. The verbatim quote is 'harder to measure than let's say a tumor size'."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: almost worse that we have the wrong. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: metrics, right? Like Biogen Idec just spent a billion dollars on this drug that reduces Alzheimer's plaques and it worked in mice and it works in people. It reduces the Alzheimer's plaque, doesn't do anything else. You still have Alzheimer's, you just don't see the plaques as bad anymore. And so they're image guided biomar, their imaging biomarker was absolutely wrong and they were completely all in on it and they're still trying to get it to work. So so you can really get led astray with these things, yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share experience",
                    "definition": "The speaker shares a relevant experience or piece of knowledge that could be useful for the discussion or project.",
                    "justification": "The speaker shares a detailed story about Biogen Idec's experience with a drug, providing insights into potential pitfalls in drug development. Evidence: \"Like Biogen Idec just spent a billion dollars on this drug that reduces Alzheimer's plaques and it worked in mice and it works in people.\""
                },
                {
                    "code_name": "offer critique",
                    "definition": "The speaker provides a critique or cautionary note that could help the group avoid mistakes.",
                    "justification": "The speaker critiques the approach of relying on certain metrics or biomarkers without proper validation, highlighting the risks. Evidence: \"So you can really get led astray with these things, yeah.\""
                },
                {
                    "code_name": "discuss limitation",
                    "definition": "The speaker points out limitations or challenges related to the topic of discussion.",
                    "justification": "The speaker discusses the limitation of using certain metrics for measuring drug efficacy, highlighting that even if a drug reduces Alzheimer's plaques, it doesn't necessarily improve the condition. Evidence: \"It reduces the Alzheimer's plaque, doesn't do anything else. You still have Alzheimer's, you just don't see the plaques as bad anymore.\""
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: Any anything positive to say in this direction to balance what I've done to the conversation? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "seek feedback",
                    "definition": "The speaker is seeking feedback or a positive comment to balance out their previous contribution.",
                    "justification": "The speaker says 'Any anything positive to say in this direction to balance what I've done to the conversation?' which indicates a desire for feedback or a positive comment."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: It's a world of opportunity. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "offer optimism",
                    "definition": "The speaker expresses a positive outlook or hopefulness regarding the situation or topic at hand.",
                    "justification": "The exact quote 'It's a world of opportunity' serves as evidence. This phrase is often used to express that despite current challenges, there are many possibilities for improvement or success."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: understanding. So maybe on Ben's point. So basically this drug reduced the plaques in Alzheimer's and in mice it also reduced symptoms but in humans it didn't reduce symptoms. Is that correct? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a specific topic.",
                    "justification": "The question 'Is that correct?' indicates the speaker is seeking confirmation or clarification. Quote: 'Is that correct?'"
                },
                {
                    "code_name": "build upon",
                    "definition": "The speaker is adding to or developing an idea previously mentioned.",
                    "justification": "The phrase 'So maybe on Ben's point' indicates the speaker is directly addressing a previous idea. Quote: 'So maybe on Ben's point.'"
                },
                {
                    "code_name": "summarize",
                    "definition": "The speaker is condensing information to clarify or ensure understanding.",
                    "justification": "The phrase 'So basically' is used to summarize. Quote: 'So basically this drug reduced the plaques in Alzheimer's and in mice it also reduced symptoms but in humans it didn't reduce symptoms.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Yeah. That's Aducanumab is the story there. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "confirm",
                    "definition": "The speaker confirms or acknowledges a previous statement made by another participant.",
                    "justification": "The utterance starts with 'Yeah,' indicating agreement, and directly relates to a previous discussion about Aducanumab."
                },
                {
                    "code_name": "provide info",
                    "definition": "The speaker provides information or shares knowledge on the topic of discussion.",
                    "justification": "By mentioning 'That's Aducanumab is the story there,' Benjamin Bartelle is providing a concise summary or additional detail about Aducanumab."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: Okay, interesting. And does are there any ideas why or it's completely unknown? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information, clarification, or confirmation about a topic.",
                    "justification": "The utterance 'And does are there any ideas why or it's completely unknown? ' is a clear indication of seeking information."
                },
                {
                    "code_name": "seek clarification",
                    "definition": "The speaker is seeking further explanation or details about something already mentioned.",
                    "justification": "The phrase 'And does are there any ideas why or it's completely unknown? ' indicates the speaker wants to understand the reasons or possible explanations for something discussed earlier."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: The the amyloid hypothesis um was you know super popular this gets back to Crystal's original point, which is uh people get hung up stuck on these mechanisms and they seem to be what you're after and in mice these amyloid plaques removal of the amyloid plaques was highly correlated with the um positive outcomes in these Alzheimer's models. We don't know if the Alzheimer's models are accurate. We don't know if Alzheimer's plaques that you see are anyway like related directly to Alzheimer's in humans. Uh human patients often have Alzheimer's plaques. They often have Alzheimer's plaques and no Alzheimer's. They sometimes have no plaques and Alzheimer's. So it was enough it was enough to go on where the animals model animal models worked. So it was worth pursuing because they were getting good data here and they could see their imaging biomarker in humans work. But it turned out or ",
        "annotations": {
            "codes": [
                {
                    "code_name": "provide context",
                    "definition": "Providing background information or context to understand a point or issue.",
                    "justification": "The speaker provides background on the amyloid hypothesis and its popularity, relating it to Crystal's original point about people getting stuck on mechanisms. Evidence: 'The the amyloid hypothesis um was you know super popular this gets back to Crystal's original point'"
                },
                {
                    "code_name": "express uncertainty",
                    "definition": "Expressing doubt or uncertainty about a statement, outcome, or model.",
                    "justification": "The speaker expresses uncertainty about the accuracy of Alzheimer's models and the direct relation of Alzheimer's plaques to Alzheimer's in humans. Evidence: 'We don't know if the Alzheimer's models are accurate. We don't know if Alzheimer's plaques that you see are anyway like related directly to Alzheimer's in humans.'"
                },
                {
                    "code_name": "critique methodology",
                    "definition": "Critiquing the methodology or approach taken in research.",
                    "justification": "The speaker critiques the approach of getting 'hung up stuck on these mechanisms' and questions the relevance of amyloid plaques in mice to Alzheimer's in humans. Evidence: 'people get hung up stuck on these mechanisms... We don't know if Alzheimer's plaques that you see are anyway like related directly to Alzheimer's in humans.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: That's crazy. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express surprise",
                    "definition": "Expressing surprise or astonishment at something.",
                    "justification": "The utterance 'That's crazy.' is a clear expression of surprise. The verbatim quote is 'That's crazy.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I mean the case is still they're still making their case. There's their other companies based on the same amyloid hypothesis still testing the same thing. There may be some condition where it works but as yet it it does not work. So ",
        "annotations": {
            "codes": [
                {
                    "code_name": "critique",
                    "definition": "Expressing a negative opinion or evaluation about something.",
                    "justification": "The speaker critiques the approach or progress of other companies/researchers, 'There may be some condition where it works but as yet it does not work. So.'"
                },
                {
                    "code_name": "update",
                    "definition": "Giving information about the current state of something.",
                    "justification": "The speaker provides an update on the status of research related to the amyloid hypothesis, 'There's their other companies based on the same amyloid hypothesis still testing the same thing.'"
                },
                {
                    "code_name": "uncertainty",
                    "definition": "Expressing a lack of knowledge or certainty about something.",
                    "justification": "The speaker expresses uncertainty about the effectiveness of the approach, 'There may be some condition where it works but as yet it does not work.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: That's crazy. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express surprise",
                    "definition": "Expressing astonishment or surprise at what was just said.",
                    "justification": "The utterance 'That's crazy.' is a clear expression of surprise or astonishment, reacting to the context provided by Benjamin Bartelle about the amyloid hypothesis and its implications."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Where did they go wrong? Did they go wrong in dish where they saw these amyloid plaques and got completely locked in on it? Did they go wrong in their animal models? Is that actually relevant to mice where the plaques are important for mice and cured them? Or is there something else going on in humans where we're just not seeing that part? Like we're getting half of it. You have it's maybe it's necessary but not sufficient. We don't know any of that stuff yet just because the human work is so slow and the one molecular marker we spent so much time on, you know these great pet tracers for Alzheimer's plaques. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is posing a question to seek information or clarification.",
                    "justification": "The utterance starts with 'Where did they go wrong?' and continues with several interrogative sentences."
                },
                {
                    "code_name": "offer criticism",
                    "definition": "The speaker is expressing a negative opinion or critique about a previous action or decision.",
                    "justification": "The speaker seems to be critiquing the approach taken by others."
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker is suggesting a new idea or perspective for consideration.",
                    "justification": "The speaker is exploring different possibilities for where previous research might have gone wrong."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: That's crazy. Why? Oh, that's yeah, amazing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express surprise",
                    "definition": "Expressing astonishment or disbelief at something.",
                    "justification": "The phrase 'That's crazy' is used to express surprise."
                },
                {
                    "code_name": "ask question",
                    "definition": "Seeking information or clarification by asking a question.",
                    "justification": "The word 'Why?' is a clear example of asking for a reason or explanation."
                },
                {
                    "code_name": "express agreement",
                    "definition": "Showing concurrence or positive evaluation.",
                    "justification": "The phrase 'Oh, that's yeah, amazing' shows agreement or admiration."
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: I I mean maybe one way to distill one of these issues is the time scale of knowing efficacy in humans is way too long. Um I don't know how like is there a way to work backwards? I I'm I'm not sure. Um but to to always go from small to big could mean that an entire direction is not wasted but mistargeted. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a potential solution or approach to address a problem.",
                    "justification": "The speaker proposes considering the time scale of knowing efficacy in humans and potentially working backwards. Evidence: 'maybe one way to distill one of these issues is the time scale of knowing efficacy in humans is way too long' and 'to always go from small to big could mean that an entire direction is not wasted but mistargeted.'"
                },
                {
                    "code_name": "ask question",
                    "definition": "The speaker seeks information or clarification.",
                    "justification": "The speaker asks for a potential solution. Evidence: 'Um I don't know how like is there a way to work backwards?'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: What if the mechanism for Alzheimer's the disease progression in Alzheimer's in human beings has never actually been seen because you can't recapitulate it in a dish and you can't recapitulate it in a mouse. I don't I don't know but what if that's true then everything we're doing is wrong in Alzheimer's. And as yet there are no there are no root cause treatments for any neurodegeneration and maybe it's because we're not seeing it because we're not looking in the right place. It's possible. A world of opportunity. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Speculate",
                    "definition": "Proposing a hypothetical scenario or idea without asserting it as a fact.",
                    "justification": "The utterance starts with 'What if,' which introduces a speculative scenario. The exact quote is: 'What if the mechanism for Alzheimer's the disease progression in Alzheimer's in human beings has never actually been seen because you can't recapitulate it in a dish and you can't recapitulate it in a mouse.'"
                },
                {
                    "code_name": "Question Current Research Methods",
                    "definition": "Questioning the validity or effectiveness of current research methods or approaches.",
                    "justification": "The speaker questions the current research methods by suggesting that they might be wrong. The exact quote is: 'then everything we're doing is wrong in Alzheimer's.'"
                },
                {
                    "code_name": "Propose New Perspectives",
                    "definition": "Suggesting new viewpoints or areas to explore.",
                    "justification": "The speaker suggests that maybe the issue is not being looked at from the right angle, indicating a need for a new perspective. The exact quote is: 'maybe it's because we're not seeing it because we're not looking in the right place.'"
                }
            ]
        }
    },
    {
        "utterance": "Molly Bright: We'll always have a job. Um but it's ",
        "annotations": {
            "codes": [
                {
                    "code_name": "make a general statement",
                    "definition": "The speaker makes a broad or general statement.",
                    "justification": "The statement 'We'll always have a job' is a general statement about job security."
                },
                {
                    "code_name": "acknowledge uncertainty",
                    "definition": "The speaker acknowledges a lack of knowledge or uncertainty.",
                    "justification": "The 'Um' and the trailing off after 'but it's' suggest uncertainty."
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: Molly, I think your question is good about time scales, right? And the the very last question of our group 2.3 topic is can we integrate imaging across time to see the impact of a previous dosing over weeks to months or can you integrate, you know, biologic processes over time to capture something that might be a longer um longer in the making and longer in the resolution. It's tough. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "endorse",
                    "definition": "Expressing agreement or support for a previous statement.",
                    "justification": "Mark Sellmyer says, 'Molly, I think your question is good about time scales, right?' This shows he is supporting Molly's question."
                },
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new idea or perspective for discussion.",
                    "justification": "Mark Sellmyer mentions, 'can we integrate imaging across time to see the impact of a previous dosing over weeks to months or can you integrate, you know, biologic processes over time to capture something that might be a longer um longer in the making and longer in the resolution.' This presents an idea for potential discussion."
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: There are people doing primate research to do exactly this, right? So there was a whole session that the ORIP had about the importance of primate research, which again still isn't the same, but at least it scales up to um to us as primates. But I think that is the same it's the same thing again, right? Super expensive, very time consuming, still not exactly the same physiology and there's no guarantee that it will directly translate to humans. So so I don't know what I said. I don't think I added anything, but I just wanted to bring that up again that it we do have a way to test um it's just it's not efficient and it's super hard. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Reference Existing Research",
                    "definition": "The speaker mentions or references existing research or studies related to the topic of discussion.",
                    "justification": "The utterance mentions existing research on primate research."
                },
                {
                    "code_name": "Express Concern about Methodology",
                    "definition": "The speaker expresses concerns or limitations about a particular methodology or approach.",
                    "justification": "The speaker highlights limitations of primate research."
                },
                {
                    "code_name": "Self-Doubt/ Humble Contribution",
                    "definition": "The speaker expresses doubt about their contribution or seeks to downplay their input.",
                    "justification": "The speaker expresses doubt about their contribution."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Millions of dollars going into marmosets for this exact reason of like maybe if mice don't tell us, maybe marmosets will. Millions being invested. Every every big neuroscience lab in America is is putting together their marmoset program in the hopes that it's going to be relevant. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a viewpoint or suggestion for consideration.",
                    "justification": "The speaker suggests considering marmosets if mice don't provide answers, as in: 'maybe if mice don't tell us, maybe marmosets will.'"
                },
                {
                    "code_name": "share information",
                    "definition": "Providing data or facts to inform others.",
                    "justification": "The speaker shares information about investment and lab activities: 'Millions being invested. Every every big neuroscience lab in America is is putting together their marmoset program in the hopes that it's going to be relevant.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: Right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Do we see a future in genetic reporters in human beings? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is posing a query to others, seeking information or opinions.",
                    "justification": "The utterance starts with 'Do we see a future,' which is a clear inquiry. The exact quote is 'Do we see a future in genetic reporters in human beings?'"
                },
                {
                    "code_name": "explore potential",
                    "definition": "The speaker is inquiring about the possibilities or future applications of a specific topic, in this case, genetic reporters in human beings.",
                    "justification": "The question is directly about exploring the potential of genetic reporters, as evidenced by 'Do we see a future in genetic reporters in human beings?'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I do. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express agreement",
                    "definition": "The act of showing concurrence or support for an idea or proposal.",
                    "justification": "The utterance 'I do.' is a direct response to 'Do we see a future in genetic reporters in human beings?' showing agreement with the possibility of a future in genetic reporters in human beings. Evidence: 'I do.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: Yeah. It seemed impossible 10 years ago, but now with I mean everyone's everyone's getting into a cell based therapy and what do you how are you going to track those things? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker poses a query to others, seeking information or clarification.",
                    "justification": "The speaker asks 'and what do you how are you going to track those things?'"
                },
                {
                    "code_name": "discuss trend",
                    "definition": "The speaker mentions or elaborates on a trend or development in the field.",
                    "justification": "The speaker mentions 'It seemed impossible 10 years ago, but now with I mean everyone's everyone's getting into a cell based therapy'."
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: But what I really don't think about as scientists often to uh is is is scary as hell. You don't have the background when someone says I'm going to put this cell in you is not your cell or it's your cell and I changed it a little bit. That is where we are that's where we're starting from with most of the general public because we're bought in because we know details. And communication is very difficult. We don't even pay science communicators very much. They they barely even exist to be honest. They're all freelancers out there. Um and so I I I I I'm afraid that that's going to fall on us. So so when Crystal was talking I was like, Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "The speaker voices a worry or issue related to the discussion topic.",
                    "justification": "The speaker expresses concern about communicating complex scientific concepts to the general public. Evidence: 'But what I really don't think about as scientists often to uh is is is scary as hell.'"
                },
                {
                    "code_name": "provide explanation",
                    "definition": "The speaker offers an explanation or elaboration on a topic.",
                    "justification": "The speaker explains the challenges in communicating scientific concepts to the general public. Evidence: 'You don't have the background when someone says I'm going to put this cell in you is not your cell or it's your cell and I changed it a little bit.'"
                },
                {
                    "code_name": "mention challenge",
                    "definition": "The speaker points out a difficulty or obstacle related to the topic.",
                    "justification": "The speaker highlights the challenge in communication due to the lack of professional science communicators. Evidence: 'We don't even pay science communicators very much. They they barely even exist to be honest. They're all freelancers out there.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Do we see a future in genetic reporters in human beings? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is inquiring about information or opinions regarding a specific topic.",
                    "justification": "The utterance 'Do we see a future in genetic reporters in human beings?' is a clear inquiry about the prospects of genetic reporters in humans."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I do. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express agreement",
                    "definition": "The speaker confirms or agrees with a previous statement or question.",
                    "justification": "The utterance 'I do.' is a direct response to a question, indicating agreement. The exact quote is 'I do.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: It's like that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agreement",
                    "definition": "The speaker is expressing agreement with a previous statement.",
                    "justification": "The utterance 'It's like that' agrees with previous discussions, for instance, Dylan Burnette's comments on science communication challenges."
                },
                {
                    "code_name": "acknowledgment",
                    "definition": "The speaker is acknowledging a previous statement without necessarily adding new information.",
                    "justification": "The phrase serves as an acknowledgment of previous statements, similar to 'uh-huh' or 'yeah'."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Yeah. Let's do it. Let's go. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Express Agreement",
                    "definition": "Expressing concurrence or confirmation with a previous statement or proposal.",
                    "justification": "The utterance starts with 'Yeah,' which is a common way to express agreement."
                },
                {
                    "code_name": "Show Enthusiasm",
                    "definition": "Displaying excitement or eagerness about an idea or proposal.",
                    "justification": "The phrases 'Let's do it. Let's go.' clearly convey enthusiasm and eagerness to take action."
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: It's a great idea, but that requires a massive effort in science communication. And so if people won't take a vaccine to save their lives, I don't know that anybody would want to have a reporter uh inside of them. So I think we have these issues here. We are all for it. Like inject me, go for it, but um so there have to there has to be a a front of us being the scientists and the clinicians and also explaining how important and innocuous some of these things can be. They can be helpful. They can be, you know, therapeutic. They can also be um diagnostic but or theragnostics, right? That's the the term. But ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Offer Criticism",
                    "definition": "The speaker provides a negative comment or concern about an idea or proposal.",
                    "justification": "The speaker starts with 'It's a great idea, but,' indicating a criticism or concern about the idea's feasibility, specifically mentioning the need for 'a massive effort in science communication.'",
                    "quote": "It's a great idea, but that requires a massive effort in science communication."
                },
                {
                    "code_name": "Express Enthusiasm",
                    "definition": "The speaker shows excitement or support for an idea or proposal.",
                    "justification": "The speaker expresses their support with phrases like 'We are all for it. Like inject me, go for it,' indicating enthusiasm for the idea.",
                    "quote": "We are all for it. Like inject me, go for it,"
                },
                {
                    "code_name": "Propose Idea",
                    "definition": "The speaker suggests a new idea or approach.",
                    "justification": "The speaker proposes the idea that scientists and clinicians need to take a frontline role in explaining the importance and safety of certain medical interventions or technologies.",
                    "quote": "So there have to there has to be a a front of us being the scientists and the clinicians and also explaining how important and innocuous some of these things can be."
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: It's like that. It's yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Sellmyer: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: I I I ran into this yesterday. I was trying to I was trying to consent a patient to image their bacteria. And the question is is is your test going to help me in any way? Yeah. And the response is it can't because it's investigational as an imaging and diagnostic it will not change your management at all. The difference for the therapy folks is they're like we don't know. We're going to see it might help you. And so that's a huge like just big difference between therapeutic intervention trials and like diagnostic like, you know, approaches. Yeah. But but what I really don't think about as scientists often to uh is is is scary as hell. You don't have the background when someone says I'm going to put this cell in you is not your cell or it's your cell and I changed it a little bit. That is where we are that's where we're starting from with most of the general public because we're bought in because we know details. And communication is very difficult. We don't even pay science communicators very much. They they barely even exist to be honest. They're all freelancers out there. Um and so I I I I I'm afraid that that's going to fall on us. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Sharing Personal Experience",
                    "definition": "The speaker shares a personal anecdote or experience related to the discussion topic.",
                    "justification": "The speaker shares a personal experience about trying to consent a patient to image their bacteria and the challenges faced. Quote: 'I I I ran into this yesterday. I was trying to I was trying to consent a patient to image their bacteria.'"
                },
                {
                    "code_name": "Asking Question",
                    "definition": "The speaker poses a question to others in the group, seeking information or clarification.",
                    "justification": "Dylan Burnette asks a question about the potential help his test could offer. Quote: 'And the question is is is your test going to help me in any way?'"
                },
                {
                    "code_name": "Highlighting Challenges",
                    "definition": "The speaker points out difficulties or challenges related to the topic of discussion.",
                    "justification": "Dylan Burnette discusses the challenges of communication with the general public and the lack of resources for science communicators. Quote: 'And communication is very difficult. We don't even pay science communicators very much. They they barely even exist to be honest.'"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: and that they shouldn't be, but maybe they should, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express_uncertainty",
                    "definition": "The speaker is expressing doubt or uncertainty about a particular topic or idea.",
                    "justification": "The utterance 'and that they shouldn't be, but maybe they should, right?' shows the speaker is questioning or uncertain about something."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, well, there's another approach, uh, you know, when you're talking about cell-based therapies and you need to track those cells, you don't necessarily have to have a permanent, you know, imaging reporter in your body, you could just label cells before you inject them with some kind of a label that is visible for the scanner, whether it's magnetic label, you know, I'm a nanoparticle person, so obviously, um, that's what what comes to mind, but also what's biodegradable and gets, you know, gets outside your body at some point. So that doesn't seem so scary, does it? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a new method or approach to a problem.",
                    "justification": "Dr. Anna Moore proposes an alternative approach to tracking cells in cell-based therapies. Quote: 'you could just label cells before you inject them with some kind of a label that is visible for the scanner'"
                },
                {
                    "code_name": "provide expertise",
                    "definition": "The speaker shares their specific knowledge or experience in a particular area.",
                    "justification": "Dr. Anna Moore shares her expertise as a nanoparticle person. Quote: 'I'm a nanoparticle person, so obviously, um, that's what what comes to mind'"
                },
                {
                    "code_name": "mitigate concern",
                    "definition": "The speaker attempts to make a problem seem less severe or intimidating.",
                    "justification": "Dr. Anna Moore tries to make the approach seem less scary. Quote: 'So that doesn't seem so scary, does it?'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: longitudinally, I've I've had very little success with that. If you're trying to look at something over months, the chances you're going to find that nanoparticle laden T cell or that nanoparticle laden, you know, stem cell and have it persist over the months you need to follow the disease progression or therapy progression. Like we've been trying that for a long time since before I started grad school and it's just without having that genetic persistence, it hasn't worked. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share experience",
                    "definition": "The speaker describes their own research experience, often including challenges or lessons learned.",
                    "justification": "The utterance starts with 'longitudinally, I've I've had very little success with that,' which clearly indicates the speaker is sharing their personal experience."
                },
                {
                    "code_name": "express skepticism",
                    "definition": "The speaker voices doubt or a negative assessment about a particular method or approach.",
                    "justification": "The statement 'without having that genetic persistence, it hasn't worked' indicates a negative outcome."
                },
                {
                    "code_name": "provide explanation",
                    "definition": "The speaker offers reasons or explanations for a phenomenon or outcome.",
                    "justification": "The detailed explanation about the necessity of genetic persistence for long-term success in tracking nanoparticle-laden cells is provided."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, I'm just saying like, you know, that's that's one problem with we can talk we can actually talk about that because our experience is that you could follow them for quite some time providing that cells do not divide because if they divide, then they dilute the material obviously. And and there has to be complementary methods to basically see the effect of your therapy. So you cannot kill, you know, many bunnies with one I I hate even saying that. That doesn't sound good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a suggestion or potential solution to a problem.",
                    "justification": "there has to be complementary methods to basically see the effect of your therapy."
                },
                {
                    "code_name": "share experience",
                    "definition": "Providing personal or professional experience as evidence or context.",
                    "justification": "our experience is that you could follow them for quite some time providing that cells do not divide"
                },
                {
                    "code_name": "express concern",
                    "definition": "Voicing a worry or a potential issue.",
                    "justification": "So you cannot kill, you know, many bunnies with one I I hate even saying that. That doesn't sound good."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I've never heard this analogy, so. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express uncertainty",
                    "definition": "The speaker expresses a lack of knowledge or uncertainty about a topic.",
                    "justification": "The utterance 'I've never heard this analogy, so.' directly expresses Benjamin Bartelle's unfamiliarity with the analogy being discussed."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: No. So, um, okay, so we got a, we got a warning, uh, T minus 15 minutes till the end of our. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: So basically what I was trying to say, I think you need more than one modality and more than one imaging, uh, you know, to even monitor one process. It seems like, you know, it has to be several different approaches just to make sure that your cells are injected, that they get where they have to go, uh, how much get lost on the way, whether they're doing what they're supposed to do, uh, and whether there's any improvement. So like right there it's like 1.5, like four, four different things that you need to monitor and you need four different ways to do that. I don't believe that there is like this universal contrast agent that can, you know, you can inject it and it's going to monitor everything. It doesn't exist. So anyway, so, um, like I said, we have, uh, 14 minutes now. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Propose Idea",
                    "definition": "The speaker suggests a new idea or approach to a problem.",
                    "justification": "The speaker proposes that more than one modality and more than one imaging technique are needed to monitor a process effectively. Evidence: 'I think you need more than one modality and more than one imaging, uh, you know, to even monitor one process.'"
                },
                {
                    "code_name": "List Challenges",
                    "definition": "The speaker identifies specific challenges or difficulties related to the research or problem at hand.",
                    "justification": "The speaker outlines several challenges in monitoring cells, including ensuring they are injected correctly, tracking them, and assessing their function and improvement. Evidence: 'just to make sure that your cells are injected, that they get where they have to go, uh, how much get lost on the way, whether they're doing what they're supposed to do, uh, and whether there's any improvement.'"
                },
                {
                    "code_name": "Express Skepticism",
                    "definition": "The speaker is expressing doubt about a particular idea or concept.",
                    "justification": "The speaker expresses skepticism about the existence of a universal contrast agent that can monitor everything. Evidence: 'I don't believe that there is like this universal contrast agent that can, you know, you can inject it and it's going to monitor everything. It doesn't exist.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: I just put down whatever I'm hearing. So I think for the next 10 minutes, can we just uh, uh, each say or just uh, input like what is the most exciting idea you heard in this meeting or you you are summarizing and we put three major ideas in in the chat instead of uh, everything. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose_process",
                    "definition": "The speaker suggests a method or procedure for the group to follow.",
                    "justification": "The speaker says, 'So I think for the next 10 minutes, can we just uh, uh, each say or just uh, input like what is the most exciting idea you heard in this meeting or you you are summarizing and we put three major ideas in in the chat instead of uh, everything.' This quote indicates proposing a process for group discussion."
                },
                {
                    "code_name": "summarize",
                    "definition": "The speaker attempts to summarize ideas or suggest that others should summarize.",
                    "justification": "The speaker mentions, 'or you are summarizing,' which directly refers to summarizing ideas."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: So, so summarizing, I think um, Anna said it pretty well, so it has to be a combination of multimodal approaches uh, for these four different processes. I hear the delivery process and then the efficacy process. The other two I didn't catch it. So. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "summarizing",
                    "definition": "Summarizing previous points to ensure understanding and consolidate ideas.",
                    "justification": "The speaker starts with 'So, so summarizing' and references Anna's previous points."
                },
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a potential solution or approach to a problem.",
                    "justification": "The speaker suggests 'it has to be a combination of multimodal approaches'."
                },
                {
                    "code_name": "request clarification",
                    "definition": "Seeking additional information or clarification on previous points.",
                    "justification": "The speaker mentions 'The other two I didn't catch it'."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, the other thing is delivery process and then, uh, you want to be able to monitor what you delivered, if it's still there, if it's still intact, if it's still functioning. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new idea or aspect to consider.",
                    "justification": "The speaker introduces a new idea by saying 'Well, the other thing is delivery process'."
                },
                {
                    "code_name": "specify requirements",
                    "definition": "Outlining specific needs or requirements for a process or project.",
                    "justification": "The speaker outlines the need to monitor the delivery by saying 'you want to be able to monitor what you delivered, if it's still there, if it's still intact, if it's still functioning.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: You know, like say the cells, right? The cell therapy, uh, are they still functioning? Are they still like for example with islet transplantation, you put islets in the human body and 60% of them dead two weeks after transplantation. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The act of posing a query to seek information.",
                    "justification": "The utterance contains a direct question, 'are they still functioning?'"
                },
                {
                    "code_name": "provide example",
                    "definition": "The act of offering a specific instance or case to illustrate a point.",
                    "justification": "The speaker provides a specific example to elaborate on their question, 'like for example with islet transplantation, you put islets in the human body and 60% of them dead two weeks after transplantation.'"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: And you don't know where they went, you don't know what they're doing, you don't know if they're producing insulin, you're blind completely. And each, uh, islet batch comes from a donor who's obviously deceased. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "highlight limitation",
                    "definition": "The speaker points out a challenge or limitation in the current understanding or methodology.",
                    "justification": "The speaker states, \"And you don't know where they went, you don't know what they're doing, you don't know if they're producing insulin, you're blind completely.\" This shows a clear highlighting of the limitations in monitoring or understanding the behavior of transplanted cells."
                },
                {
                    "code_name": "provide information",
                    "definition": "The speaker provides relevant information to the discussion.",
                    "justification": "The speaker mentions, \"And each, uh, islet batch comes from a donor who's obviously deceased.\" This provides specific information about the source of islet batches."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: So it's just an example. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Mhm. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: One idea that I think is super exciting is this idea of long-term genetic reporters. It is high risk, it is very controversial, but um, but for auto imaging they provide really good contrast and they they're they're almost forever if they don't get injected, ejected out of the body. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a new concept or suggestion for discussion or consideration.",
                    "justification": "The speaker proposes an idea: 'One idea that I think is super exciting is this idea of long-term genetic reporters.'"
                },
                {
                    "code_name": "highlight potential benefits",
                    "definition": "Pointing out the advantages or positive aspects of an idea.",
                    "justification": "The speaker highlights benefits: 'but for auto imaging they provide really good contrast'"
                },
                {
                    "code_name": "acknowledge challenges",
                    "definition": "Recognizing potential problems or downsides of an idea.",
                    "justification": "The speaker acknowledges challenges: 'It is high risk, it is very controversial'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Genetic reporter, I'm all for it. I have one. Anyone wants it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express enthusiasm/support",
                    "definition": "Expressing a positive sentiment towards an idea or proposal.",
                    "justification": "The speaker says 'Genetic reporter, I'm all for it', indicating support for the idea."
                },
                {
                    "code_name": "offer",
                    "definition": "The act of providing something for others to use or take.",
                    "justification": "The speaker offers a genetic reporter they have, saying 'I have one. Anyone wants it.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: We bring up theranostic a lot. We've said that a number of times. Um, and it's the great thing to say, um, but what exactly is a theranostic when we go through it and it neither needs to be um, some nanotechnology, some macromolecular complex that is detectable and sensitive to a specific readout or it needs to be uh an engineered cell that uh is detectable and then can change its its signal or shape. You need to have that level of complexity to have a theranostic. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is inquiring about a specific topic or seeking clarification on something.",
                    "justification": "The speaker asks for clarification on what a theranostic is, indicating a desire to understand the concept better. Evidence: 'but what exactly is a theranostic when we go through it'."
                },
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a notion or concept, potentially for discussion or consideration.",
                    "justification": "The speaker discusses the components or types of theranostics, suggesting a framework for understanding the concept. Evidence: 'it neither needs to be um, some nanotechnology, some macromolecular complex that is detectable and sensitive to a specific readout or it needs to be uh an engineered cell that uh is detectable and then can change its its signal or shape'."
                },
                {
                    "code_name": "clarify concept",
                    "definition": "The speaker attempts to provide a clearer understanding or definition of a concept.",
                    "justification": "The speaker tries to define what a theranostic is by explaining its necessary characteristics. Evidence: 'You need to have that level of complexity to have a theranostic'."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Oh, it has to be for the right mechanism. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "Expressing a concern or a condition that needs to be met.",
                    "justification": "The speaker, Benjamin Bartelle, expresses a concern about the mechanism, 'Oh, it has to be for the right mechanism.' The phrase 'has to be' indicates a requirement or a condition that needs to be met."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I think that was the thing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Okay. ",
        "annotations": {}
    },
    {
        "utterance": "Dylan Burnette: But we haven't really talked too much about toxicity and the ability to actually detect uh tissue that is dying either through necrosis or apoptosis or some either programmed or not programmed cell death. It's something that is would be quite useful I think if you're putting drugs into people and then you want to drugs where they go where they go, but if they're causing damage along the way or when they get concentrated at the side of of where they're supposed to be at, it's hard to tell. Um, and I know in in in neurobiology if you actually saw the neurons dying that wouldn't be bad. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express concern",
                    "definition": "Expressing a worry or problem about something.",
                    "justification": "The speaker expresses concern about not discussing toxicity and the ability to detect dying tissues: 'But we haven't really talked too much about toxicity and the ability to actually detect uh tissue that is dying...'."
                },
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new concept, method, or approach.",
                    "justification": "The speaker proposes that detecting dying tissues would be useful: 'It's something that is would be quite useful I think if you're putting drugs into people...'"
                },
                {
                    "code_name": "reference existing knowledge",
                    "definition": "Mentioning existing information or research.",
                    "justification": "The speaker references existing knowledge in neurobiology: 'Um, and I know in in in neurobiology if you actually saw the neurons dying that wouldn't be bad.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: So you're saying cell death as a target for our imaging and theranostic then. Like understanding that. Yeah, so if you had a read out to to to actually monitor uh the the target tissues uh actual death or not because sometimes in the case of cancer you want to kill these things, but sometimes you don't want to kill it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "paraphrase",
                    "definition": "Repeating back what one has understood from others' statements to ensure alignment and understanding.",
                    "justification": "The speaker paraphrases the previous discussion to show understanding: 'So you're saying cell death as a target for our imaging and theranostic then. Like understanding that.'"
                },
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new idea, approach, or solution.",
                    "justification": "The speaker proposes an idea for monitoring target tissues: 'Yeah, so if you had a read out to to to actually monitor uh the the target tissues uh actual death or not...'"
                },
                {
                    "code_name": "highlight challenge",
                    "definition": "Pointing out difficulties, complexities, or considerations relevant to the discussion.",
                    "justification": "The speaker highlights a challenge in cancer treatment: 'because sometimes in the case of cancer you want to kill these things, but sometimes you don't want to kill it.'"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: So so it could be both targeted and just a general read out of toxicity because sometimes you don't want your cells to die. Um, as a matter of fact, I don't want more of my cells to die in general. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a potential approach or concept.",
                    "justification": "The speaker suggests having both targeted and general readouts of toxicity. Evidence: 'So so it could be both targeted and just a general read out of toxicity'."
                },
                {
                    "code_name": "express concern",
                    "definition": "Voicing a worry or issue.",
                    "justification": "The speaker expresses a concern about cell death. Evidence: 'Um, as a matter of fact, I don't want more of my cells to die in general'."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Well, a long time ago there was an an an ex in five probes developed, I would say 20 years ago to monitor tumor response to therapy. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: just like, oh, everything's ferroptosis, right? ",
        "annotations": {}
    },
    {
        "utterance": "Dylan Burnette: Um, but uh, but so it's it's probably impossible to have one particular marker to pull off, you know, actually knowing what kind of of cell death, but it would be nice to know if cells are alive or not inside of of a biotic. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "speculate",
                    "definition": "Making a statement that expresses a possibility or impossibility based on the speaker's current knowledge or perspective.",
                    "justification": "The utterance contains 'it's probably impossible to have one particular marker...' which shows speculation about the feasibility of having a marker."
                },
                {
                    "code_name": "express wish",
                    "definition": "Expressing a desire or wish for something to be possible or to happen.",
                    "justification": "The utterance includes 'but it would be nice to know if cells are alive or not...' which expresses a desire for knowledge about cell status."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay. So, um, so let's see. So, um, Sision, do you do you feel comfortable talking about those things? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask_permission",
                    "definition": "The speaker seeks permission or checks comfort level regarding a topic.",
                    "justification": "The exact quote is 'do you feel comfortable talking about those things?' which directly relates to seeking permission."
                },
                {
                    "code_name": "seek_input",
                    "definition": "The speaker asks for someone's thoughts or opinions on a matter.",
                    "justification": "The phrase 'do you feel comfortable talking about those things?' also implies seeking Sision's input or opinion on whether they are comfortable discussing the topics."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Actually, uh, yeah, I I think I can only catch understand like 50% of these conversations. I think my biology is probably high school level, so. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express limitation",
                    "definition": "The speaker explicitly states their limitations or lack of expertise.",
                    "justification": "The speaker states 'I think my biology is probably high school level' as evidence of their self-assessed limitation. This shows they are aware of their knowledge gap."
                },
                {
                    "code_name": "show willingness to defer",
                    "definition": "The speaker expresses willingness to let others take over or contribute.",
                    "justification": "The speaker says 'So if anybody wants to take over, I'm totally comfortable' which indicates they are open to others taking the lead."
                },
                {
                    "code_name": "express humility",
                    "definition": "The speaker downplays their abilities or contributions.",
                    "justification": "The speaker states 'I think I can only catch understand like 50% of these conversations' which shows they are downplaying their understanding of the topic."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: That's pretty good though. 50%'s pretty good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "offer encouragement",
                    "definition": "The speaker provides supportive or reassuring comments to another participant.",
                    "justification": "The utterance 'That's pretty good though. 50%'s pretty good.' is a supportive comment to Sixian You, who previously mentioned that they only understood 50% of the conversation. The quote '50%'s pretty good' is evidence of this encouragement."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: So if anybody wants to take over, I'm totally comfortable because I think the best thing is that we present the best ideas in the room. Um, yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "delegate",
                    "definition": "The speaker offers to let someone else take control or responsibility.",
                    "justification": "The speaker says 'So if anybody wants to take over, I'm totally comfortable' indicating a willingness to delegate or pass on responsibility."
                },
                {
                    "code_name": "emphasize idea quality",
                    "definition": "The speaker stresses the importance of presenting the best ideas.",
                    "justification": "The speaker mentions 'I think the best thing is that we present the best ideas in the room' to emphasize the focus on quality ideas."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Nah, you got this. Come on. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "encourage",
                    "definition": "The speaker provides encouragement or support to the listener, urging them to proceed with confidence.",
                    "justification": "The utterance 'Nah, you got this. Come on.' is a clear example of encouragement, urging Sixian You to proceed and indicating support and confidence in their abilities."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Okay. So. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Do we we have our our barriers, our targets, our agents, our approaches. This is all getting really well organized, so I. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is inquiring about the presence or status of specific items or concepts.",
                    "justification": "The speaker asks, 'Do we we have our our barriers, our targets, our agents, our approaches.'"
                },
                {
                    "code_name": "provide positive feedback",
                    "definition": "The speaker is giving a positive comment about the progress or state of something.",
                    "justification": "The speaker states, 'This is all getting really well organized, so I.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Oh. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none",
                    "definition": "No relevant behavior observed",
                    "justification": "The utterance 'Oh.' is a very short expression and does not convey any specific behavior related to collaboration, team formation, or grant success."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I think it's really shaping up. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express optimism",
                    "definition": "The speaker expresses a positive sentiment about the progress or state of the discussion.",
                    "justification": "The speaker says 'I think it's really shaping up.' which indicates a positive outlook on the discussion's progress. The verbatim quote is 'I think it's really shaping up.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Okay. So, uh, I guess to start, we can kind of present to the room like what are the barriers? Uh, and the barriers of course, disparity between the models and uh, the lack of understanding, uh, and the lack of tools to um, to validate toxicity and efficacy uh, in the short timeline. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose discussion topic",
                    "definition": "The act of suggesting a topic for discussion or proposing an agenda item.",
                    "justification": "The speaker suggests discussing barriers: 'Okay. So, uh, I guess to start, we can kind of present to the room like what are the barriers?'"
                },
                {
                    "code_name": "identify barrier",
                    "definition": "The act of pointing out a specific challenge or obstacle related to the project or problem domain.",
                    "justification": "The speaker lists specific barriers: 'and the barriers of course, disparity between the models and uh, the lack of understanding, uh, and the lack of tools to um, to validate toxicity and efficacy uh, in the short timeline.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: And then to address that, we could first we could um, focus more efforts on different targets, uh, list at this and then contrast agency is another effort and then uh, in the end it will be a combination multi model approaches of all this. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker suggests a potential idea or approach to solve a problem or address an issue.",
                    "justification": "The utterance 'we could first we could um, focus more efforts on different targets' shows that the speaker is proposing an idea. The verbatim quote is 'we could first we could um, focus more efforts on different targets.'"
                },
                {
                    "code_name": "suggest solution",
                    "definition": "The speaker offers a potential solution to a problem that has been identified.",
                    "justification": "The suggestion to 'focus more efforts on different targets' and considering 'contrast agency is another effort' can be seen as suggesting solutions. The verbatim quote is 'focus more efforts on different targets' and 'contrast agency is another effort.'"
                },
                {
                    "code_name": "outline plan",
                    "definition": "The speaker lays out a series of steps or approaches to be taken.",
                    "justification": "The utterance outlines a plan by mentioning 'focus more efforts on different targets,' 'list at this,' and 'in the end it will be a combination multi model approaches of all this.' The verbatim quote is 'And then to address that, we could first we could um, focus more efforts on different targets, uh, list at this and then contrast agency is another effort and then uh, in the end it will be a combination multi model approaches of all this.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Where does imaging come in? The multimodal approaches in the contrast agents? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking clarification or information on a topic.",
                    "justification": "The utterance 'Where does imaging come in? The multimodal approaches in the contrast agents?' is a clear question seeking to understand the role or position of imaging and multimodal approaches within the context being discussed."
                },
                {
                    "code_name": "seek clarification",
                    "definition": "The speaker is seeking to make something clearer or to understand a point better.",
                    "justification": "The question 'Where does imaging come in?' directly seeks clarification on the role or position of imaging, implying that the speaker wants a clearer understanding of its relevance or integration within the discussed context."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Yeah. I mean that's what we mean by multimodal, multimodal imaging. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "clarify",
                    "definition": "Provide additional information to clarify a previous statement.",
                    "justification": "The speaker clarifies the meaning of 'multimodal' by adding 'multimodal imaging'. Evidence: 'Yeah. I mean that's what we mean by multimodal, multimodal imaging.'"
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: Well, and also in the technological development, right, to be able to actually see the efficacy of these things live in an organism. Someday. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Suggesting a new idea or approach for consideration.",
                    "justification": "The speaker proposes the idea of technological development to see efficacy in an organism, evidenced by 'to be able to actually see the efficacy of these things live in an organism. Someday.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Is is is multimodal approaches a subset of technological development then? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "ask question",
                    "definition": "The speaker is seeking information or clarification on a topic.",
                    "justification": "The utterance 'Is is is multimodal approaches a subset of technological development then?' is a direct question seeking clarification."
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: It is. Yes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Express agreement or confirmation with a previous statement.",
                    "justification": "The utterance 'It is. Yes.' indicates agreement with a previous statement. The verbatim quote 'It is. Yes.' shows that Crystal Rogers is confirming her previous statement or someone else's statement."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Yeah. Uh-huh. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "The speaker acknowledges or agrees with a previous statement.",
                    "justification": "The utterance 'Yeah. Uh-huh.' is a clear indication of agreement or acknowledgment. The verbatim quote is 'Yeah. Uh-huh.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: I guess all this stuff then. These things are all like uh development of 3D culture, visualization of delivery. That's all tech development that we're all tracking. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "summarize",
                    "definition": "The speaker is summarizing or acknowledging previous discussion points.",
                    "justification": "The phrase 'I guess all this stuff then' indicates an attempt to summarize or come to a conclusion based on previous discussions."
                },
                {
                    "code_name": "list ideas",
                    "definition": "The speaker is listing specific ideas or areas of discussion.",
                    "justification": "The utterance lists specific ideas: 'development of 3D culture, visualization of delivery'."
                },
                {
                    "code_name": "identify common ground",
                    "definition": "The speaker is highlighting or assuming shared interests or goals.",
                    "justification": "The phrase 'That's all tech development that we're all tracking' assumes shared interests."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: So, I can delete this and uh, put multimodal approaches here. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose solution",
                    "definition": "The speaker suggests a concrete action to take in the discussion.",
                    "justification": "The speaker suggests deleting something and putting 'multimodal approaches' elsewhere. Evidence: 'So, I can delete this and uh, put multimodal approaches here.'"
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Crystal Rogers: I think the 3D cell culture stuff is also part of technological development, bioprinting, etc. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "Presenting a suggestion or concept for discussion.",
                    "justification": "The speaker is suggesting that 'the 3D cell culture stuff is also part of technological development, bioprinting, etc.' as a idea to be considered. Quote: 'I think the 3D cell culture stuff is also part of technological development, bioprinting, etc.'"
                },
                {
                    "code_name": "provide information",
                    "definition": "Sharing knowledge or facts related to the discussion.",
                    "justification": "The speaker is providing information about the relationship between 3D cell culture and technological development. Quote: 'I think the 3D cell culture stuff is also part of technological development, bioprinting, etc.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Uh, that is also, okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "acknowledge",
                    "definition": "The speaker acknowledges or shows understanding of what has been said, often without adding new information.",
                    "justification": "The utterance 'Uh, that is also, okay. .' serves as an acknowledgment of a previous statement. The use of 'okay' explicitly indicates agreement or acceptance."
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: I think we talked about this before. Yeah, particle, nanoparticle is already in the contrast agents. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "reference_previous_discussion",
                    "definition": "The speaker refers to a previous discussion or point made, indicating a recall of past conversation or decisions.",
                    "justification": "The phrase 'I think we talked about this before' directly indicates that the speaker is referencing a previous discussion."
                },
                {
                    "code_name": "provide_information",
                    "definition": "The speaker offers information or facts relevant to the discussion.",
                    "justification": "The utterance 'Yeah, particle, nanoparticle is already in the contrast agents' provides specific information about the topic being discussed, indicating that certain concepts (particle, nanoparticle) are already included in the contrast agents."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: You can make the the font smaller too if it doesn't fit. That's uh that's the easy one. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi: I also want to add the concept of like live contrast agents, like what happens with magnetotactic bacteria because like the dilution of the like the contrast agent is a big problem in the like the cell proliferation. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "propose idea",
                    "definition": "The speaker introduces a new concept or idea.",
                    "justification": "The speaker says, 'I also want to add the concept of like live contrast agents,' which introduces a new idea."
                },
                {
                    "code_name": "identify problem",
                    "definition": "The speaker points out a challenge or issue.",
                    "justification": "The speaker mentions, 'the dilution of the like the contrast agent is a big problem in the like the cell proliferation,' highlighting a problem."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: That's inherent in genetic reporters, right? That's what we mean when we say a live contrast agent. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "make statement",
                    "definition": "The speaker is expressing a fact or opinion.",
                    "justification": "The phrase 'That's inherent in genetic reporters, right?' shows an assertion about genetic reporters, and 'That's what we mean when we say a live contrast agent' further clarifies the statement."
                },
                {
                    "code_name": "seek agreement",
                    "definition": "The speaker is looking for validation or confirmation from others.",
                    "justification": "The word 'right' in 'That's inherent in genetic reporters, right?' is used to seek agreement."
                },
                {
                    "code_name": "clarify",
                    "definition": "The speaker is providing more information to make something clearer.",
                    "justification": "The phrase 'That's what we mean when we say a live contrast agent' serves to clarify the concept of a live contrast agent."
                }
            ]
        }
    },
    {
        "utterance": "Morteza Mahmoudi: So the live contrast like there are papers coming out showing basically that magnetotactic bacteria can be used for like even increasing the like uh imaging uh sensitivity and capacity at the side of like for cell therapy applications, they they at least they showed promising results. So maybe adding. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "share_info",
                    "definition": "The speaker provides information, data, or references to support their point.",
                    "justification": "The speaker mentions specific research findings, 'there are papers coming out showing basically that magnetotactic bacteria can be used for like even increasing the like uh imaging uh sensitivity and capacity at the side of like for cell therapy applications,' which serves as a basis for their suggestion."
                },
                {
                    "code_name": "propose_idea",
                    "definition": "The speaker suggests a new idea or approach.",
                    "justification": "The speaker suggests adding something, 'So maybe adding,' which indicates the proposal of a new idea or consideration for inclusion."
                }
            ]
        }
    },
    {
        "utterance": "Benjamin Bartelle: That's inherent in genetic reporters, right? That's what we mean when we say a live contrast agent. It's a a live reporter. I mean, I I agree. I agree with you completely. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Expressing concurrence or alignment with someone else's idea or statement.",
                    "justification": "The speaker says, 'I mean, I I agree. I agree with you completely.' This clearly indicates agreement."
                },
                {
                    "code_name": "explain",
                    "definition": "Providing additional details or clarification about something.",
                    "justification": "The speaker explains, 'That's inherent in genetic reporters, right? That's what we mean when we say a live contrast agent. It's a a live reporter.' This provides an explanation of the concept."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Okay, we have uh probably one or a little bit over one minute left. So I just wanted to say that uh I I think it was fun. I think you know, I think we discussed a lot of different questions because the topic is so broad. And um if you guys you know, if you guys want to talk more about it, you know, my email is there. Uh you can email me or you can email each other. Please, um and uh hopefully we'll get this going and uh I'm looking forward to forming proposals from you guys. Just think what what you want to do. Um, you have complimentary expertise. Um, so we have a clinical person here. That's unique. So grab his expertise before it's too late. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Encourage Collaboration",
                    "definition": "The speaker encourages others to collaborate or communicate with each other.",
                    "justification": "The speaker says, 'if you guys want to talk more about it, you know, my email is there. Uh you can email me or you can email each other.'"
                },
                {
                    "code_name": "Express Interest in Proposal Development",
                    "definition": "The speaker expresses interest or enthusiasm about developing proposals.",
                    "justification": "The speaker mentions, 'I'm looking forward to forming proposals from you guys.'"
                },
                {
                    "code_name": "Highlight Complementary Expertise",
                    "definition": "The speaker points out the diverse or complementary skills and expertise within the group.",
                    "justification": "The speaker notes, 'you have complimentary expertise. Um, so we have a clinical person here. That's unique. So grab his expertise before it's too late.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: Thanks everyone. I feel like I learned a lot as a physics engineering person and I really appreciated the discussion. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "express appreciation",
                    "definition": "Expressing gratitude or appreciation towards others for an experience or discussion.",
                    "justification": "The utterance starts with 'Thanks everyone' and continues with 'I really appreciated the discussion,' which clearly shows appreciation."
                },
                {
                    "code_name": "reflect on learning",
                    "definition": "Reflecting on what was learned from an experience or discussion.",
                    "justification": "The phrase 'I feel like I learned a lot as a physics engineering person' indicates reflection on personal learning."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Me too. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Expression of agreement with a previous statement.",
                    "justification": "The utterance 'Me too.' is a direct expression of agreement, showing solidarity with a previous sentiment or statement. Exact quote: 'Me too.'"
                }
            ]
        }
    },
    {
        "utterance": "Sixian You: Yeah, I learned all the all the dark size and potentially price size of therapy. What I learned again is biology is so hard and medicine is so hard. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "reflection",
                    "definition": "Participant reflects on their learning or understanding.",
                    "justification": "The participant states, 'Yeah, I learned all the all the dark size and potentially price size of therapy.' This indicates they are reflecting on what they learned."
                },
                {
                    "code_name": "express_challenge",
                    "definition": "Participant expresses a challenge or difficulty.",
                    "justification": "The participant mentions, 'What I learned again is biology is so hard and medicine is so hard.' This shows they are expressing the challenges they perceive in biology and medicine."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Poulikakos: I really really liked what Crystal said about the communication being key as we do push forward with anything shiny and new. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agree",
                    "definition": "Express agreement with a previous statement.",
                    "justification": "The speaker explicitly agrees with Molly's statement."
                },
                {
                    "code_name": "highlight key point",
                    "definition": "Emphasize a crucial aspect or takeaway from the discussion.",
                    "justification": "The speaker highlights a key point made by Molly."
                }
            ]
        }
    },
    {
        "utterance": "Dr. Anna Moore: Yeah, I totally agree. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Dylan Burnette: And I liked what Molly said about the difficulty with integrating over time scales and and having tractable metrics for many of the different diseases. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "agreement",
                    "definition": "Expressing agreement or confirmation with a previous statement.",
                    "justification": "The utterance starts with 'And I liked what Molly said,' which indicates agreement or approval of Molly's statement."
                },
                {
                    "code_name": "problem_identification",
                    "definition": "Identifying a problem or challenge.",
                    "justification": "The utterance mentions specific challenges: 'the difficulty with integrating over time scales and... having tractable metrics for many of the different diseases.'"
                },
                {
                    "code_name": "build_on_others",
                    "definition": "Building on or referencing others' ideas.",
                    "justification": "The entire utterance is about building on Molly's idea by mentioning it and elaborating on it."
                }
            ]
        }
    }
]